Reza Rachman 22010112110033 Lap.KTI Bab7
DAFTAR PUSTAKA
1. G.K. Gupta, Agrawal Deepika , R.K. Arya, Prevalence risk factors and socio
demographic co – relates of adolescent hypertension in district
Ghaziabad.Indian Journal of community Health [internet]. c2013 [cited 2016
Jan 20]: 25(3):296-301. Available from: http://www.iapsmupuk.org/journal.
2. WHO. Non Communicable Disease: Hypertension [internet]. c2011 [cited
2015 Nov 11]. Available from: http://www.searo.who.int/.
3. Balitbang Kemenkes RI. Riset Kesehatan Dasar; RISKESDAS. Jakarta:
Balitbang Kemenkes RI; 2013.
4. RSUD RAA Soewondo. Profil RSUD RAA. Soewondo Pati Tahun 2014.
Pati: RSUD RAA Soewondo; 2014.
5. RSUD RAA Soewondo. 2014. Profil RSUD RAA. Soewondo Pati Tahun
2012. Pati: RSUD RAA Soewondo; 2014.
6. RSUD RAA Soewondo. Profil RSUD RAA. Soewondo Pati Tahun 2013.
Pati: RSUD RAA Soewondo; 2014.
7. Babatsikou F, Zavitsanou A. Epidemiology of hypertension in the eldery.
Health Sciene Journal [internet]. c2004 [cited 2015 dec 11] 4(10): 24-30.
Available from : http://www.hsj.gr/medicine/
8. Kim K, Kim YM, Kim EK. Correlation Between the Activities of Daily
Living of Stroke Patients in a Community Setting and Their Quality of Life.
Journal of Physical Therapy Science [internet]. c2014; 26 (3): 417-9.
Available from: http://www.ncbi.nlm.nih.gov
9. Anggraini, dkk. Faktor-faktor yang Berhubungan dengan Kejadian Hipertensi
pada Pasien yang Berobat di Poliklinik Dewasa Puskesmas Bangkinang
Periode Januari sampai Juni 2008 [internet]. c2009 [cited 2015 Nov 25].
Available from: http://yayanakhyar.files.wordpress.com/2009/
10. Chataut J, Adhikari RK, Sinha NP. Prevalence and Risk Factor for
Hypertension in Adults Living in Central Development Region in
Nepal.Kathmandu University Medical Journal [internet]. c2011 [cited 2015
Nov 25] 9(1):13-8. Available from: www.ncbi.com
82
83
11. Kartikasari. Faktor Risiko Hipertensi Pada Masyarakat di Desa Kabongan
Kidul, Kabupaten Rembang [Skripsi] Semarang: Universitas Diponegoro;
2012.
12. Achmad Choirun Ni’am, Berapa Faktor Resiko yang Berhubungan dengan
Kejadian Hipertensi,[Skripsi] Semarang; Universitas Muhammadiyah
Smearang; 2010.
13. Eva Puspita, dkk. Faktor Risiko Kejadian Hipertensi Pada Pasien yang
Berobat di Poliklinik Rumah Sakit Umum Daerah Labuang Baji
Makasar.Jurnal Ilmiah Kesehatan Diagnosis [internet]. c2014 [cited 2015
Nov 25]: 5(1):59-64.Available from: http:// library.stikesnh.ac.id
14. Charbel El Bcheraoui, Ziad A. Memish, Marwa Tuffaha, et al., Hypertension
and Its Associated Risk Factors in the Kingdom of Saudi Arabia, 2013: A
National Survey. International Journal of Hypertension [internet]. c2014
[cited
2015
Nov
25]:
2014(3);1-8.Available
from
:
www.hindawi.com/journals/
15. Syer Ree Tee dkk The Prevalence Of Hypertension And Its Associated Risk
Factors In Two Rural Communities In Penang, Malaysi.International eJournal of Science,Medicine dan education [internet]. c2010 [cited 2015 Nov
22]: 9(3):1-27. Available from : http://web.imu.edu.my/ejournal
16. Q Wei, J Sun, dkk. Prevalence of hypertension and associated risk factors in
Dehui City of Jilin Province in China.Journal of Human Hypertension
[internet]. c2015 [cited 2015 Nov 22]: 32(29), 64–8. Available from :
http://www.nature.com/jhh/journal
17. Reddy S S, Prabhu G R. Prevalence and Risk Factors of Hypertension in
Adults in an Urban Slum, Tirupati, A.P. Indian J Community Med [internet].
c2005 [cited 2016 Jan 20]: 30(3):84-6. Available from :
http://www.ijcm.org.in
18. Sathya Prakash Manimunda, dkk. Association of hypertension with risk
factors & hypertension related behaviour among the aboriginal Nicobarese
tribe living in Car Nicobar Island, Indi. Indian J Med Res [internet]. c2011
[cited 2016 Jan 20] ;133(3): 287–93. Available from :
http://www.ncbi.nlm.nih.gov
19. Gupta G.K, dkk. Prevalence risk factors and socio demographic co – relates
of adolescent hypertension in district Ghaziabad.Indian Journal of community
Health [internet]. c2013 [cited 2016 Jan 20]: 25(3):296-301. Available from :
https://doaj.org/toc/2248-9509/25/3
20. Mukhtar Z. Perubahan Hemodinamik dan Terapi Hipertensi dari Aspek
Kardiovaskuler. 1996. Jakarta: Bamboedoea. p: 24-5.
84
21. Sheldon G. Sheps. Mayo Clinic Hipertension (Terjemahan). Jakarta: Intisari
Mediatama; 2005. p: 26, 158.
22. Siregar TGM. Hipertesi esensial. Dalam: Rilantono et al. (ed). Buku ajar
kardiologi. 2003. Jakarta: FKUI
23. Yogiantoro M. Hipertensi Esensial. Dalam: Sudoyo et al. (ed). Buku ajar ilmu
penyakit dalam. Jilid I edisi IV. Jakarta: FKUI; 2006. p: 610-14.
24. Sheps SG. Mayo Clinic Hipertension (Terjemahan). Jakarta: Intisari
Mediatama; 2005. p: 26, 158.
25. Dharmeizar. Hipertensi. Medicinus Scientific Journal of Pharmacheutical
Development and Medical Application [internet]. c2012 [cited 2016 Jan 14].
25(10):5-6. Available from : http://www.dexa-medica.com
26. Andrea. Korelasi Derajat Hipertensi dengan Stadium Penyakit Ginjal Kronik
Di RSUP DR Kariadi periode 2008 - 2012 [Skripsi] Semarang: Universitas
Diponegoro; 2013.
27. Sari AAP, Kristiana IGAAW, dan Ayu NLPM. Gambaran Faktor-faktor
Determinan pada Pasien Hipertensi di Desa Sudimara Kecamatan Tabanan,
Kabupaten Tabanan Mei 2010 [internet]. c2010 [cited 2015 Nov 27]. p: 8.
Available from: http:// dc252.4shared.com/doc/
28. Martin J. Hypertension Guidelines: Revisiting The JNC 7 Recommendations.
The Journal of Lancaster General Hospital [internet]. c2008 [cited 2015 Des
6]: 3 (3):91-7. Available from : http://www.jlgh.org/JLGH/media/Journal
29. Mansjoer A, dkk. Kapita Selekta Kedokteran Jilid I: Nefrologi dan
Hipertensi. Jakarta: Media Aesculapius FK UI; 2001. p: 519-20.
30. Klasifikasi Hipertensi [internet]. c2009 Sep 14 [cited 2015 Nov 27].
Available from: http://www.dokter-medis.blogspot.com/
31. Kaplan NM. Primary Hipertension: pathogenesis. Kaplan’s clinical
Hypertension. 10th edition. Philadelphia: Lippincot Williams & Wilkins;
2010. p. 44-108.
32. Klabunde R. Cardiovascular Physiologi Concept. Philadelphia: Lippincot
Williams & Wilkins; 2005.
33. Lopez-Sendon J, Swedenberg K, Mcmurray J, et al. Expert consensus
document on b-adrenergic receptor blocker: The Task Force on Beta-Blocker
of the European Society of Cardioligy. Eur Heart J. 2004; 25:1341-62.
85
34. de Groot AA, Mathy MJ, van Zwieten PA, et al. Involvement of the B3
Adrenoreceptor in Nebivolol-Induced Vasorelaxtion in Rat Aorta. J
Cardiovasc Pharmacol. 2003; 42:232-60.
35. Dzau VJ, Braundwald E, Resolved and unresolved issue in the prevention and
treatment of coronary artery disease: a workshop consensus steatment. Am
Heart J. 1991; 121:1244-63
36. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modiable risk
factor assosiated with myocardial infraction in 52 countries (the
INTERHEART study): case-control study. Lancet. 2004; 364:937-52.
37. Victor RG, Pathophysiology of Target-Organ Disease: Dose Angiotensin II
Remain The Key. J Clin Hypertension. 2007; 9(11): S4
38. Dzau VJ, Antman EM, Black HR, et al. The cardiovascular Disease
Continuum Validated: Clinical Evidence of Improved Patient Outcome.
Circulation. 2006; 114:2850-70.
39. Bonetti PO, Lerman LO, Lerman A. Endotelial Dysfungtion: A marker of
Atherosklerotic Risk. Arterioscler Thtomb Vasc Biol. 2003; 23:168-75.
40. Willerson JT, Kereiakes DJ. Endotelial dysfungtion. Circulation 2003; 108:
2060-1.
41. Strawn WB, Ferrario CM. Mechanism linking Angiotensin II and
Atherogenesis, Curr Opin Lipidol. 2002; 13:505-52.
42. Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Suzuki Y, Mezzano S,
Plaza JJ, Egido J. Role of the Renin Angiotensin System in Vasculare
Disease: Expending the Field. Hyperthension. 2001; 38: 1382.
43. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, dkk.
Hope study Investigators. Albuminuria and risk of cardiovascular events,
death, and heart failure in diabetic and non diabetic individuals. JAMA. 2001;
286: 421-6.
44. Lindholm LH, Ibsen H, Dahlof B, dkk. Cardiovaskular morbidity and
mortality in patients with diabetes in the Losartan Intervention for Endpoint
reduction in hypertension study (LIFE): a randomized trial against atenolol.
Lancet. 2002; 359:1004-10.
45. Hanifa A. Prevalensi Hipertensi Sebagai Penyebab Penyakit Ginjal Kronik Di
Unit Hemodialisis RSUP H.Adam Malik Medan Tahun 2009 [internet].
c2010
[cited
2015
Nov
27].
p:
4-13.
Available
from:
http://repository.usu.ac.id/
86
46. Sugiarto A. Faktor-faktor Risiko Hipertensi Grade II pada Masyarakat (Studi
Kasus di Kabupaten Karanganyar) [internet]. c2007 [cited 2015 Nov 27]. p:
29-50, 90-126. Available from: http://eprints.undip.ac.id/
47. Faktor Risiko Hipertensi yang Tidak dapat Dikontrol [internet]. c2011 [cited
2015 Nov 22]. Available from: http://smallcrab.com/kesehatan/
48. Nurkhalida. Warta Kesehatan Masyarakat. Jakarta : Depkes RI; 2003. p: 1921.
49. Lam Murni BR Sagala. Perawatan Penderita Hipertensi di Rumah oleh
Keluarga Suku Batak dan Suku Jawa di Kelurahan Lau Cimba Kabanjahe
[internet]. c2011 [cited 2015 Dec 4]. p: 10-13. Available from:
http://repository.usu.ac.id/
50. Sandhya Pruthi. Menopause and High Blood Pressure [internet]. c2010 [cited
2011 Nov 26]. Available from: http://www.mayoclinic.com/health/
51. Soetjiningsih. Tumbung kembang remaja dan permasalahannya. Jakarta:
Sagung Seto; 2004. p. 77-86.
52. Festy. Hubungan perilaku orang tua dengan kejadian obesitas pada anak prasekolah (3-5 tahun) di Taman Flora kota Surabaya. Jurnal Penelitian Akademi
Kesehatan Rajekwesi Bojonegoro [internet]. c2012 [cited 2015 Dec 12]; 6(3):
22-6. Available from : https://jurnalakesrajekwesi.files
53. Anggara FHD, Prayitno N. Faktor-Faktor Yang Berhubungan dengan
Tekanan Darah di Puskesmas Telaga Murni, Cikarang Barat Tahun 2012.
Jurnal Ilmiah Kesehatan [internet]. c2013 [cited 2015 Dec 13]: 5(1):20-5.
Available from : http://lp3m.thamrin.ac.id
54. Natalia D, Hasibuan P, Hendro. Hubungan Obesitas dengan Kejadian
Hipertensi di Kecamatan Sintang, Kalimantan Barat. eJKI [internet]. c2014;
2(3):156-8. Available from : http://www.kalbemed.com/
55. Setyanda O, Sulastri D, Lestari Y. Hubungan Merokok dengan Kejadian
Hipertensi pada Laki-Laki Usia 35-65 Tahun di Kota Padang. Jurnal
Kesehatan andalas [internet]. c2015 [cited 2016 Jan 18]: 4(2): 434-9.
Available from : http://jurnal.fk.unand.ac.id.
56. Departemen Kesehatan Republik Indonesia. Pedoman Teknis Penemuan dan
Tatalaksana Penyakit Hipertensi. Jakarta: Departemen Kesehatan Republik
Indonesia; 2008. p. 14–28.
87
57. Departemen Kesehatan Republik Indonesia. Pedoman Surveilans Penyakit
Jantung dan Pembuluh Darah. Jakarta: Departemen Kesehatan Republik
Indonesia; 2008. p. 6.
58. Sherwood L. Pembuluh Darah dan Tekanan Darah. Dalam: Fisologi Manusia
dari Sel ke Sistem. Edisi 2. Jakarta: EGC; 2011. p.335–6.
59. Mukamal KJ. The Effects of Smoking on Cardiovascular Desease. Boston:
Departement of Interna Harvard Medical School; 2006. p.199.
60. Aris Sugiarto. Faktor–Faktor Risiko Hipertensi Grade II pada Masyarakat
(Studi Kasus di Kabupaten Karang Anyar) [internet]. c2007 [cited 2015 Dec
15]. p: 22-24, 77 – 79. Available from : http://eperintis.undip.ac.id/
61. National Institutes of Health. The Seventh Report of the Joint National
Committee on Prevention, Detection Evaluation, and Treatment of High
Blood Pressure, Atlanta: U. S. Department of Health and Human Services;
2004. p.31-5.
62. Brown C. Penyakit Aterosklerotik. Dalam: Price A, Wilson LM. Konsep
Klinis Proses–Proses Penyakit. Volume 1. Edisi 6. Jakarta: EGC; 2006. p.
582–7.
63. Kevin JW, John D. Nondrug Interventions for Treatment of Hypertension.
New York: Division of Cardiology University of Rochester Medical Center;
2011. p.231-89.
64. Dharmeizar. Hipertensi. Medicinus Scientific Journal of Pharmacheutical
Development and Medical Application [internet]. c2012 [cited 2016 Jan 14].
25(10):3-8. Available from : http://www.dexa-medica.com
65. Sartika, RAD. Pengaruh Lemak Trans Terhadap Kesehatan Jantung,
MAKARA Jurnal Sains [internet]. c2009 [cited 2016 Jan 10]; 13(1): 23-8.
Available from : http://jurnalkesmas.ui.ac.id
66. Shapo L, Pomerleau J, McKee M. Epidemiology of Hypertension and
Associated Cardiovascular Risk Factors in a Country in Transition. Journal
Epidemiology Community Health [internet]. c2003 [cited 2016 Jan 10];
57:734–9. Available from : http://www.ncbi.nlm.nih.gov\
67. Widyaningrum A T. Hubungan Asupan Natrium, Kalium, Magnesium dan
Status gizi dengan Tekanan Darah pada Lansia di Kalurahan Makamhaji
Kecamatan Kartasura. [internet]. c2014 [cited 2016 Jan 19]. p: 1-6. Available
from : http://eprints.ums.ac.id
88
68. Wijayanti E. Asupan Natrium dari Makanan Jajanan dan Tekanan Darah
Siswa Sekolah Dasar Studi di SD Negeri 06 Petompon. [internet]. c2010
[cited 2016 Jan 13]. p: 1. Available from : http://eprints.undip.ac.id
69. Bustan, MN. Epidemiologi penyakit menular, Jakarta: Rineka Cipta; 2007.
70. Komaling, JK, Suba, B, Wongkar, D. Hubungan Mengonsumsi Alkohol
dengan Kejadian Hipertensi pada Laki-laki Di Desa Tompasobaru II
Kecamatan Tompasobaru Kabupaten Minahasa Selatan. e-KP [internet].
c2013 [cited Jan 11]: 1(1): 25-30.
71. Susalit E, Kapojos EJ, Lubis HR. Hipertensi Primer Dalam Buku Ajar Ilmu
Penyakit Dalam, Edisi III, Jilid II, Jakarta: Balai Penerbit FKUI. 2001. p.45372.
72. Ganiswara. Farmakologi dan Terapan. Edisi IV. Jakarta: Bagian Farmakologi
FKUI; 1995. p. 317.
73. Yogiantoro, M. Hipertensi Esensial. Jakarta: Departemen Ilmu Penyakit
Dalam FKUI; 2006. p: 599-601.
74. Susalit E, Kapojos EJ, Lubis HR. Hipertensi Primer. Dalam: Buku Ajar Ilmu
Penyakit Dalam, Edisi III, Jilid II, Jakarta: Balai Penerbit FKUI. p. 453-70.
75. Mannan, H, Wahiduddin, Rismayanti. Faktor Risiko Kejadian Hipertensi di
Wilayah Kerja Puskesmas Bangkala Kabupaten Jeneponto Tahun 2011
Makassar [internet]. c2013 [cited 2016 April 18]. Available from:
http://repository.unhas.ac.id
76. Liu J, Sekine M, Tatsuse T, et al. Family history of hypertension and the risk
of overweight in Japanese children: results from the Toyama Birth Cohort
Study J Epidemiol [internet]. c2014 [cited 2016 Apr 18] 24(4):304–11.
Available from : http://www.ncbi.nlm.nih.gov/pubmed/24857956
77. Kumar V, Abbas AK, Fausto and, Hypertensive Vascular Disease. Dalam :
Robn and Cotran Pathologic basis of disease. Edisi 7. Philadeltia: Elsevier
Saunders, 2005. p. 528 – 9.
78. Pang W dkk. Prevalence of Hypertension and Associated Factors Among
Older Rural Adults: Results from Liaoning Province, China. Med Princ Pract
[internet]. c2010 [cited 2016 Apr 22]: 19(1):22–27. Available from :
http://dx.doi.org/10.1159/000252830
89
79. Niskanen L, dkk. Inflammation, abdominal obesity, and smoking as
predictors of hypertension. Hypertension [internet]. c2004 [cited 2016 Apr
24]:
44(6):859–865.
Available
from
:
http://dx.doi.org/10.1161/01.HYP.0000146691.51307.84
80. Bowman ST et al. Clinical research Hypertension. A Prospective Study of
Cigarette Smokey And Risk of Inciden Hypertension In Bringham and
women Hospital Massachucettes [internet]. c2007 [cited 2016 Apr 25] :
50(21):2085-92. Available from: www.ncbi.nlm.nih.gov/pubmed/18021879
81. Stritzke J, Markus MP, Duderstadt S. Obesity is The Main Risk factor for
Left Atrial Enlargement during Aging. The MONICA/KORA (Monitoring of
Trends and Determinations in Cardiovascular Disease/Cooperative Research
in the Region of Augsburg) Study. J Am Coll Cardiol [internet]. c2009 Nov
[cited 2016 Apr 29]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/
82. Rahyani F. Epidemiologi Penderita Hipertensi Esensial yang Dirawat di
Bagian Penyakit Dalam Perjan RS DR. M. Djamil Padang Periode 1 Januari
2002 -31 Desember 2003. Skripsi. Padang. 2005. Hal 32
83. Ball CO, Meneely GR. Observations on Dietary Sodium Chloride. J Am Diet
Assoc [internet]. c1957 [cited 2016 Apr 29 ]: 33(4):366–370. Available from
: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4105387/
84. Denton D, Weisinger R, Mundy Ni, Wickings EJ dkk. The Effect of Increased
Salt Intake on Blood Pressure of Chimpanzees. Nat Med [internet] c1995
[cited 2016 May 4]:
1(10):
1009-16. Available from
:
http://www.ncbi.nlm.nih.gov/pubmed/7489355
85. Fukui M, Tanaka M, Toda H, Senmaru T, Sakabe K, Ushigome E, Nakamura
N. Risk Factors for Development of Diabetes Mellitus, Hypertension and
Dyslipidemia. Diabetes Res Clin Pract [internet] c2011 [cited 2016 May 10].
Available from : http://dx.doi.org/10.1016/j.diabres.2011.07.006 .
86. Halperin R. O., Sesso H. D., Ma J, Buring J. E., Stampfer M. J., Gaziano J.
M. Dyslipidemia and The Risk of Incident Hypertension in Men.
Hypertension. AHA Journal [internet] c2006 [cited 2016 May 7]:47(1):45–
50. Available from : http://dx.doi.org/10.1161/01.HYP.0000196306.42418.0e
.
87. Howard DS, Nancy RC, Julie EB, JoAnn EM, Michael G. Alcohol
Consumption and the Risk of Hypertension in Women and Men.
Hypertension [internet] c2008 [cited 2016 May 7]:51(4):1080-7. Available
from : http://www.ncbi.nlm.nih.gov/pubmed/18259032
90
Lampiran 1. Analisis Univariat Beberapa Variabel Bebas Terhadap Kondisi Tekanan
Darah Subjek dengan Menggunakan Uji Chi Aquare Program SPSS
Frequency Table
Umur
Valid
>= 55
< 55
Total
Frequency
42
33
75
Perc ent
56.0
44.0
100.0
Valid Percent
56.0
44.0
100.0
Cumulative
Perc ent
56.0
100.0
Jenis Kelamin
Valid
Laki-laki
Perempuan
Total
Frequency
31
44
75
Perc ent
41.3
58.7
100.0
Valid Percent
41.3
58.7
100.0
Cumulative
Perc ent
41.3
100.0
Pendidikan
Valid
Dasar
Menengah/Tinggi
Total
Frequency
38
37
75
Perc ent
50.7
49.3
100.0
Valid Percent
50.7
49.3
100.0
Cumulative
Perc ent
50.7
100.0
91
Pekerjaan
Valid
Tidak bekerja
Buruh
Swasta
Wiraswasta
PNS/POLRI/TNI
Pensiunan
Total
Frequency
19
11
11
2
23
9
75
Percent
25.3
14.7
14.7
2.7
30.7
12.0
100.0
Valid Percent
25.3
14.7
14.7
2.7
30.7
12.0
100.0
Cumulative
Percent
25.3
40.0
54.7
57.3
88.0
100.0
Tekanan Darah
Valid
Hipertensi II
Hipertensi I
Total
Frequency
49
26
75
Perc ent
65.3
34.7
100.0
Valid Percent
65.3
34.7
100.0
Cumulative
Perc ent
65.3
100.0
BMI
Valid
Obese
Non Obese
Total
Frequency
47
28
75
Perc ent
62.7
37.3
100.0
Valid Percent
62.7
37.3
100.0
Cumulative
Perc ent
62.7
100.0
Riw. Keluarga Hipertensi
Valid
Ya
Tidak
Total
Frequency
49
26
75
Perc ent
65.3
34.7
100.0
Valid Percent
65.3
34.7
100.0
Cumulative
Perc ent
65.3
100.0
92
Konsumsi Garam
Valid
Sering
Jarang
Total
Frequency
70
5
75
Percent
93.3
6.7
100.0
Valid Percent
93.3
6.7
100.0
Cumulative
Percent
93.3
100.0
Konsumsi Lemak
Valid
Sering
Jarang
Total
Frequency
72
3
75
Percent
96.0
4.0
100.0
Valid Percent
96.0
4.0
100.0
Cumulative
Percent
96.0
100.0
Kebiasan Merokok
Valid
Ya
Tidak
Total
Frequency
17
58
75
Perc ent
22.7
77.3
100.0
Valid Percent
22.7
77.3
100.0
Cumulative
Perc ent
22.7
100.0
Konsumsi Alkohol
Valid
Ya
Tidak
Total
Frequency
4
71
75
Perc ent
5.3
94.7
100.0
Valid Percent
5.3
94.7
100.0
Cumulative
Perc ent
5.3
100.0
93
Olah raga teratur
Valid
Tidak
Ya
Total
Frequency
40
35
75
Perc ent
53.3
46.7
100.0
Valid Percent
53.3
46.7
100.0
Cumulative
Perc ent
53.3
100.0
94
Lampiran 2. Analisis Bivariat Beberapa Variabel Bebas Terhadap Kondisi Tekanan
Darah Subjek dengan Menggunakan Uji Chi Aquare Program SPSS
Umur * Tekanan Darah
Crosstab
Umur
>= 55
< 55
Total
Count
Expec ted Count
% within Tekanan Darah
Count
Expec ted Count
% within Tekanan Darah
Count
Expec ted Count
% within Tekanan Darah
Tekanan Darah
Hipertensi II Hipertensi I
27
15
27.4
14.6
55.1%
57.7%
22
11
21.6
11.4
44.9%
42.3%
49
26
49.0
26.0
100.0%
100.0%
Total
42
42.0
56.0%
33
33.0
44.0%
75
75.0
100.0%
Chi-Square Tests
Pearson Chi-Square
Continuity Correc tiona
Likelihood Ratio
Fisher's Exact Tes t
Linear-by-Linear
Association
N of Valid Cases
Value
.046b
.000
.046
.046
df
1
1
1
1
Asymp. Sig.
(2-sided)
.830
1.000
.830
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
1.000
.513
.831
75
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is 11.
44.
95
Symmetric Measures
Nominal by Nominal
N of Valid Cases
Contingency Coefficient
Value
.025
75
Approx. Sig.
.830
a. Not ass uming the null hypothesis.
b. Using the asymptotic standard error assuming the null hypothesis.
Risk Estimate
Value
Odds Ratio for Umur
(>= 55 / < 55)
For cohort Tekanan
Darah = Hipertensi II
For cohort Tekanan
Darah = Hipertensi I
N of Valid Cases
95% Confidence
Interval
Lower
Upper
.900
.344
2.351
.964
.693
1.342
1.071
.570
2.013
75
Jenis Kelamin * Tekanan Darah
Crosstab
Jenis Kelamin
Laki-laki
Perempuan
Total
Count
Expec ted Count
% within Tekanan Darah
Count
Expec ted Count
% within Tekanan Darah
Count
Expec ted Count
% within Tekanan Darah
Tekanan Darah
Hipertensi II Hipertensi I
21
10
20.3
10.7
42.9%
38.5%
28
16
28.7
15.3
57.1%
61.5%
49
26
49.0
26.0
100.0%
100.0%
Total
31
31.0
41.3%
44
44.0
58.7%
75
75.0
100.0%
96
Chi-Square Tests
Pearson Chi-Square
Continuity Correc tiona
Likelihood Ratio
Fisher's Exact Tes t
Linear-by-Linear
Association
N of Valid Cases
Value
.135b
.015
.136
.134
df
1
1
1
Asymp. Sig.
(2-sided)
.713
.903
.712
1
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
.808
.453
.715
75
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is 10.
75.
Symmetric Measures
Nominal by Nominal
N of Valid Cases
Contingency Coefficient
Value
.042
75
Approx. Sig.
.713
a. Not ass uming the null hypothesis.
b. Using the asymptotic standard error assuming the null hypothesis.
Risk Estimate
Value
Odds Ratio for Jenis
Kelamin (Laki-laki /
Perempuan)
For cohort Tekanan
Darah = Hipertensi II
For cohort Tekanan
Darah = Hipertensi I
N of Valid Cases
95% Confidence
Interval
Lower
Upper
1.200
.454
3.171
1.065
.765
1.481
.887
.467
1.687
75
97
Pendidikan * Tekanan Darah
Crosstab
Pendidikan
Dasar
Menengah/Tinggi
Total
Count
Expec ted Count
% within Tekanan Darah
Count
Expec ted Count
% within Tekanan Darah
Count
Expec ted Count
% within Tekanan Darah
Tekanan Darah
Hipertensi II Hipertensi I
24
14
24.8
13.2
49.0%
53.8%
25
12
24.2
12.8
51.0%
46.2%
49
26
49.0
26.0
100.0%
100.0%
Total
38
38.0
50.7%
37
37.0
49.3%
75
75.0
100.0%
Chi-Square Tests
Pearson Chi-Square
Continuity Correc tiona
Likelihood Ratio
Fisher's Exact Tes t
Linear-by-Linear
Association
N of Valid Cases
Value
.161b
.025
.161
.159
df
1
1
1
1
Asymp. Sig.
(2-sided)
.688
.874
.688
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
.809
.437
.690
75
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is 12.
83.
Symmetric Measures
Nominal by Nominal
N of Valid Cases
Contingency Coefficient
Value
.046
75
Approx. Sig.
.688
a. Not ass uming the null hypothesis.
b. Using the asymptotic standard error assuming the null hypothesis.
98
Risk Estimate
Value
Odds Ratio for
Pendidikan (Dasar /
Menengah/Tinggi)
For cohort Tekanan
Darah = Hipertensi II
For cohort Tekanan
Darah = Hipertensi I
N of Valid Cases
95% Confidence
Interval
Lower
Upper
.823
.317
2.134
.935
.672
1.300
1.136
.609
2.121
75
Pekerjaan * Tekanan Darah
Crosstab
Pekerjaan
Tidak bekerja
Buruh
Swasta
Wiraswasta
PNS/POLRI/TNI
Pensiunan
Total
Count
Expec ted Count
% within Tekanan Darah
Count
Expec ted Count
% within Tekanan Darah
Count
Expec ted Count
% within Tekanan Darah
Count
Expec ted Count
% within Tekanan Darah
Count
Expec ted Count
% within Tekanan Darah
Count
Expec ted Count
% within Tekanan Darah
Count
Expec ted Count
% within Tekanan Darah
Tekanan Darah
Hipertensi II Hipertensi I
10
9
12.4
6.6
20.4%
34.6%
6
5
7.2
3.8
12.2%
19.2%
10
1
7.2
3.8
20.4%
3.8%
1
1
1.3
.7
2.0%
3.8%
16
7
15.0
8.0
32.7%
26.9%
6
3
5.9
3.1
12.2%
11.5%
49
26
49.0
26.0
100.0%
100.0%
Total
19
19.0
25.3%
11
11.0
14.7%
11
11.0
14.7%
2
2.0
2.7%
23
23.0
30.7%
9
9.0
12.0%
75
75.0
100.0%
99
Chi-Square Tests
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Assoc iation
N of Valid Cases
Value
5.492a
6.160
1.106
5
5
Asymp. Sig.
(2-sided)
.359
.291
1
.293
df
75
a. 5 cells (41.7%) have expected count less than 5. The
minimum expected count is .69.
Symmetric Measures
Nominal by Nominal
N of Valid Cases
Contingency Coefficient
Value
.261
75
Approx. Sig.
.359
a. Not ass uming the null hypothesis.
b. Using the asymptotic standard error assuming the null hypothesis.
BMI * Tekanan Darah
Crosstab
BMI
Obese
Non Obese
Total
Count
Expec ted Count
% within Tekanan Darah
Count
Expec ted Count
% within Tekanan Darah
Count
Expec ted Count
% within Tekanan Darah
Tekanan Darah
Hipertensi II Hipertensi I
33
14
30.7
16.3
67.3%
53.8%
16
12
18.3
9.7
32.7%
46.2%
49
26
49.0
26.0
100.0%
100.0%
Total
47
47.0
62.7%
28
28.0
37.3%
75
75.0
100.0%
100
Chi-Square Tests
Pearson Chi-Square
Continuity Correc tiona
Likelihood Ratio
Fisher's Exact Tes t
Linear-by-Linear
Association
N of Valid Cases
Value
1.323b
.809
1.310
1.306
df
1
1
1
1
Asymp. Sig.
(2-sided)
.250
.368
.252
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
.318
.184
.253
75
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is 9.
71.
Symmetric Measures
Nominal by Nominal
N of Valid Cases
Contingency Coefficient
Value
.132
75
Approx. Sig.
.250
a. Not ass uming the null hypothesis.
b. Using the asymptotic standard error assuming the null hypothesis.
Risk Estimate
Value
Odds Ratio for BMI
(Obes e / Non Obese)
For cohort Tekanan
Darah = Hipertensi II
For cohort Tekanan
Darah = Hipertensi I
N of Valid Cases
95% Confidence
Interval
Lower
Upper
1.768
.667
4.688
1.229
.848
1.780
.695
.377
1.283
75
101
Riw. Keluarga Hipertensi * Tekanan Darah
Crosstab
Riw. Keluarga
Hipertensi
Ya
Tidak
Total
Count
Expec ted Count
% within Tekanan Darah
Count
Expec ted Count
% within Tekanan Darah
Count
Expec ted Count
% within Tekanan Darah
Tekanan Darah
Hipertensi II Hipertensi I
33
16
32.0
17.0
67.3%
61.5%
16
10
17.0
9.0
32.7%
38.5%
49
26
49.0
26.0
100.0%
100.0%
Total
49
49.0
65.3%
26
26.0
34.7%
75
75.0
100.0%
Chi-Square Tests
Pearson Chi-Square
Continuity Correc tiona
Likelihood Ratio
Fisher's Exact Tes t
Linear-by-Linear
Association
N of Valid Cases
Value
.253b
.062
.251
.250
df
1
1
1
1
Asymp. Sig.
(2-sided)
.615
.804
.616
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
.621
.399
.617
75
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is 9.
01.
Symmetric Measures
Nominal by Nominal
N of Valid Cases
Contingency Coefficient
Value
.058
75
Approx. Sig.
.615
a. Not ass uming the null hypothesis.
b. Using the asymptotic standard error assuming the null hypothesis.
102
Risk Estimate
Value
Odds Ratio for Riw.
Keluarga Hipertensi
(Ya / Tidak)
For cohort Tekanan
Darah = Hipertensi II
For cohort Tekanan
Darah = Hipertensi I
N of Valid Cases
95% Confidence
Interval
Lower
Upper
1.289
.479
3.470
1.094
.763
1.570
.849
.452
1.596
75
Konsumsi Garam * Tekanan Darah
Crosstab
Konsumsi
Garam
Sering
Jarang
Total
Count
Expec ted Count
% within Tekanan Darah
Count
Expec ted Count
% within Tekanan Darah
Count
Expec ted Count
% within Tekanan Darah
Tekanan Darah
Hipertensi II Hipertensi I
45
25
45.7
24.3
91.8%
96.2%
4
1
3.3
1.7
8.2%
3.8%
49
26
49.0
26.0
100.0%
100.0%
Total
70
70.0
93.3%
5
5.0
6.7%
75
75.0
100.0%
103
Chi-Square Tests
Pearson Chi-Square
Continuity Correc tiona
Likelihood Ratio
Fisher's Exact Tes t
Linear-by-Linear
Association
N of Valid Cases
Value
.509b
.052
.554
Asymp. Sig.
(2-sided)
.476
.820
.457
df
1
1
1
.502
1
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
.653
.430
.479
75
a. Computed only for a 2x2 table
b. 2 cells (50.0%) have expected count les s than 5. The minimum expected count is 1.
73.
Symmetric Measures
Nominal by Nominal
N of Valid Cases
Value
.082
75
Contingency Coefficient
Approx. Sig.
.476
a. Not ass uming the null hypothesis.
b. Using the asymptotic standard error assuming the null hypothesis.
Risk Estimate
Value
Odds Ratio for Konsums i
Garam (Sering / Jarang)
For cohort Tekanan Darah
= Hipertensi II
For cohort Tekanan Darah
= Hipertensi I
N of Valid Cases
95% Confidence
Interval
Lower
Upper
.450
.048
4.249
.804
.501
1.288
1.786
.301
10.600
75
104
Konsumsi Lemak * Tekanan Darah
Crosstab
Konsumsi
Lemak
Sering
Jarang
Total
Count
Expec ted Count
% within Tekanan Darah
Count
Expec ted Count
% within Tekanan Darah
Count
Expec ted Count
% within Tekanan Darah
Tekanan Darah
Hipertensi II Hipertensi I
47
25
47.0
25.0
95.9%
96.2%
2
1
2.0
1.0
4.1%
3.8%
49
26
49.0
26.0
100.0%
100.0%
Total
72
72.0
96.0%
3
3.0
4.0%
75
75.0
100.0%
Chi-Square Tests
Pearson Chi-Square
Continuity Correc tiona
Likelihood Ratio
Fisher's Exact Tes t
Linear-by-Linear
Association
N of Valid Cases
Value
.002b
.000
.002
.002
df
1
1
1
1
Asymp. Sig.
(2-sided)
.960
1.000
.960
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
1.000
.726
.961
75
a. Computed only for a 2x2 table
b. 2 cells (50.0%) have expected count les s than 5. The minimum expected count is 1.
04.
Symmetric Measures
Nominal by Nominal
N of Valid Cases
Contingency Coefficient
Value
.006
75
Approx. Sig.
.960
a. Not ass uming the null hypothesis.
b. Using the asymptotic standard error assuming the null hypothesis.
105
Risk Estimate
Value
Odds Ratio for Konsums i
Lemak (Sering / Jarang)
For cohort Tekanan Darah
= Hipertensi II
For cohort Tekanan Darah
= Hipertensi I
N of Valid Cases
95% Confidence
Interval
Lower
Upper
.940
.081
10.882
.979
.432
2.218
1.042
.204
5.324
75
Kebiasan Merokok * Tekanan Darah
Crosstab
Kebiasan
Merokok
Ya
Tidak
Total
Count
Expec ted Count
% within Tekanan Darah
Count
Expec ted Count
% within Tekanan Darah
Count
Expec ted Count
% within Tekanan Darah
Tekanan Darah
Hipertensi II Hipertensi I
9
8
11.1
5.9
18.4%
30.8%
40
18
37.9
20.1
81.6%
69.2%
49
26
49.0
26.0
100.0%
100.0%
Total
17
17.0
22.7%
58
58.0
77.3%
75
75.0
100.0%
106
Chi-Square Tests
Value
1.490b
.867
1.448
Pearson Chi-Square
Continuity Correc tiona
Likelihood Ratio
Fisher's Exact Tes t
Linear-by-Linear
Association
N of Valid Cases
df
1
1
1
1.471
Asymp. Sig.
(2-sided)
.222
.352
.229
1
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
.255
.175
.225
75
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is 5.
89.
Symmetric Measures
Nominal by Nominal
N of Valid Cases
Contingency Coefficient
Value
.140
75
Approx. Sig.
.222
a. Not ass uming the null hypothesis.
b. Using the asymptotic standard error assuming the null hypothesis.
Risk Estimate
Value
Odds Ratio for Kebiasan
Merokok (Ya / Tidak)
For cohort Tekanan
Darah = Hipertensi II
For cohort Tekanan
Darah = Hipertensi I
N of Valid Cases
95% Confidence
Interval
Lower
Upper
.506
.168
1.525
.768
.475
1.241
1.516
.805
2.857
75
107
Konsumsi Alkohol * Tekanan Darah
Crosstab
Konsumsi
Alkohol
Ya
Tidak
Total
Count
Expected Count
% within Tekanan Darah
Count
Expected Count
% within Tekanan Darah
Count
Expected Count
% within Tekanan Darah
Tekanan Darah
Hipertensi II Hipertensi I
2
2
2.6
1.4
4.1%
7.7%
47
24
46.4
24.6
95.9%
92.3%
49
26
49.0
26.0
100.0%
100.0%
Total
4
4.0
5.3%
71
71.0
94.7%
75
75.0
100.0%
Chi-Square Tests
Pearson Chi-Square
Continuity Correc tiona
Likelihood Ratio
Fisher's Exact Tes t
Linear-by-Linear
Association
N of Valid Cases
Value
.439b
.015
.419
.433
df
1
1
1
1
Asymp. Sig.
(2-sided)
.508
.903
.518
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
.606
.432
.511
75
a. Computed only for a 2x2 table
b. 2 cells (50.0%) have expected count les s than 5. The minimum expected count is 1.
39.
Symmetric Measures
Nominal by Nominal
N of Valid Cases
Contingency Coefficient
Value
.076
75
Approx. Sig.
.508
a. Not ass uming the null hypothesis.
b. Using the asymptotic standard error assuming the null hypothesis.
108
Risk Estimate
Value
Odds Ratio for Konsums i
Alkohol (Ya / Tidak)
For cohort Tekanan Darah
= Hipertensi II
For cohort Tekanan Darah
= Hipertensi I
N of Valid Cases
95% Confidence
Interval
Lower
Upper
.511
.068
3.852
.755
.280
2.041
1.479
.527
4.154
75
Olah raga teratur * Tekanan Darah
Crosstab
Olah raga
teratur
Tidak
Ya
Total
Count
Expec ted Count
% within Tekanan Darah
Count
Expec ted Count
% within Tekanan Darah
Count
Expec ted Count
% within Tekanan Darah
Tekanan Darah
Hipertensi II Hipertensi I
27
13
26.1
13.9
55.1%
50.0%
22
13
22.9
12.1
44.9%
50.0%
49
26
49.0
26.0
100.0%
100.0%
Total
40
40.0
53.3%
35
35.0
46.7%
75
75.0
100.0%
109
Chi-Square Tests
Value
.178b
.032
.178
Pearson Chi-Square
Continuity Correc tiona
Likelihood Ratio
Fisher's Exact Tes t
Linear-by-Linear
Association
N of Valid Cases
.175
df
1
1
1
1
Asymp. Sig.
(2-sided)
.673
.858
.674
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
.809
.429
.675
75
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is 12.
13.
Symmetric Measures
Nominal by Nominal
N of Valid Cases
Contingency Coefficient
Value
.049
75
Approx. Sig.
.673
a. Not ass uming the null hypothesis.
b. Using the asymptotic standard error assuming the null hypothesis.
Risk Estimate
Value
Odds Ratio for Olah
raga teratur (Tidak / Ya)
For cohort Tekanan
Darah = Hipertensi II
For cohort Tekanan
Darah = Hipertensi I
N of Valid Cases
95% Confidence
Interval
Lower
Upper
1.227
.473
3.182
1.074
.769
1.499
.875
.470
1.628
75
110
Lampiran 3. Analisis Multivariat Beberapa Variabel yang Berhubungan dengan Kondisi
Tekanan Darah Subjek dengan Menggunakan Regresi Logistik Berganda Metode
Backward Stepwise (Likelihood Ratio) pada Program SPSS
Logistic Regression
Block 1: Method = Backward Stepwise (Likelihood Ratio)
Variables in the Equation
Step
a
1
Step
a
2
Step
a
3
BMI
Merokok
Obat
Constant
BMI
Obat
Constant
Obat
Constant
B
.723
-.261
1.222
-2.728
.755
1.298
-3.328
1.164
-2.105
S.E.
.533
.615
.605
1.835
.527
.579
1.185
.558
.757
Wald
1.843
.180
4.073
2.211
2.051
5.022
7.890
4.345
7.740
df
1
1
1
1
1
1
1
1
1
Sig.
.175
.672
.044
.137
.152
.025
.005
.037
.005
a. Variable(s) entered on step 1: BMI, Merokok, Obat.
Tabel Karakteristik Data
Variabel
n
%
≥ 55
42
56
< 55
33
44
Laki-laki
31
41,3
Perempuan
44
58,7
Dasar
38
50,7
Menengah/tinggi
37
49,3
Umur
Jenis kelamin
Pendidikan
Pekerjaan
Exp(B)
2.061
.770
3.394
.065
2.127
3.661
.036
3.203
.122
95.0% C.I.for EXP(B)
Lower
Upper
.725
5.854
.231
2.573
1.036
11.118
.757
1.177
5.975
11.392
1.072
9.571
111
Tidak bekerja
19
25,3
Buruh
11
14,7
Swasta
11
14,7
Wiraswasta
2
2,7
PNS/POLRI/TNI
23
30,7
Pensiunan
9
12
Hipertensi II
49
65,3
Hipertensi I
26
34,7
Obese
47
62,7
Non obese
28
37,3
Ya
49
65,3
Tidak
26
34,7
Sering
70
93,3
Jarang
5
6,7
Sering
72
96
Jarang
3
4
Ya
17
22,7
Tidak
58
77,3
Ya
4
5,3
Tidak
71
94,7
Tekanan darah
BMI
Riw. Keluarga hipertensi
Konsumsi garam
Konsumsi lemak
Kebiasaan merokok
Konsumsi alkohol
Olah raga teratur
112
Tidak
40
53,3
Ya
35
46,7
Tabel Hasil Uji Chi Square
Hipertensi
Variabel
II
I
n
%
n
%
≥ 55
27
55,1
15
57,7
< 55
22
44,9
11
42,3
Laki-laki
21
42,9
10
38,5
Perempuan
28
57,1
16
61,5
Dasar
24
49
14
53,8
Menengah/tinggi
25
51
12
46,2
Tidak bekerja
10
20,4
9
34,6
Buruh
6
12,2
5
19,2
Swasta
10
20,4
1
3,8
Wiraswasta
1
2
1
3,8
PNS/POLRI/TNI
16
32,7
7
26,9
Pensiunan
6
12,2
3
11,5
Obese
33
67,3
14
53,8
Non obese
16
32,7
12
46,2
p
r
IK 95%
0,830§
0,025
0,9 (0,34 – 2,35)
0,713§
0,042
1,2 (0,45 – 3,17)
0,688§
0,046
0,82 (0,32 – 2,13)
0,359§
0,261
–
0,250§
0,132
1,77 (0,67 – 4,69)
Umur
Jenis kelamin
Pendidikan
Pekerjaan
BMI
Riw. Keluarga
113
hipertensi
Ya
33
67,3
16
61,5
Tidak
16
32,7
10
38,5
Sering
45
91,8
25
96,2
Jarang
4
8,2
1
3,8
Sering
47
95,9
25
96,2
Jarang
2
4,1
1
3,8
Ya
9
18,4
8
30,8
Tidak
40
81,6
18
69,2
Ya
2
4,1
2
7,7
Tidak
47
95,9
24
92,3
Tidak
27
55,1
13
50
Ya
22
44,9
13
50
0,615§
0,058
1,29 (0,48 – 3,47)
0,653¥
0,082
0,45 (0,05 – 4,25)
1,000¥
0,006
0,94 (0,08 – 10,88)
0,222§
0,140
0,51 (0,17 – 1,53)
0,606¥
0,076
0,51 (0,07 – 3,85)
0,673§
0,049
1,23 (0,47 – 3,18)
Konsumsi garam
Konsumsi lemak
Kebiasaan merokok
Konsumsi alkohol
Olah raga teratur
Ket: * Signifikan; ¥ Fisher’s Exact Test; § Pearson Chi Square
114
Tabel Hasil Uji Regresi Logistik
Step
1
2
3
Variabel
B
p
Ext(B)
IK 95%
0,723
0,175
2,061
0,73 – 5,85
Merokok
-0,261
0,672
0,770
0,23 – 2,57
Konstanta
-2,728
0,137
0,065
0,755
0,152
2,127
Konstanta
-3,328
0,005
0,036
Konstanta
-2,105
0,005
0,122
BMI
BMI
0,76 – 5,98
115
Lampiran 4. Surat Pernyataan Persetujuan (Inform Consent)
Surat Pernyataan Persetujuan sebagai Sampel Penelitian
(Informed Consent)
Saya yang bertanda tangan di bawah ini,
Menyatakan dengan kesungguhannya bahwa saya bersedia untuk menjadi sampel
penelitian mahasiswa S-1 Pendidikan Dokter dengan judul “Faktor Risiko Kejadian
Hipertensi pada Pasien yang Berobat di Poliklinik RSUD RAA Soewondo Pati”, dengan
menjawab setiap pertanyaan yang ada pada kuesioner dengan jujur dan apa adanya.
Informasi yang saudara berikan akan dijaga kerahasiaannya. Penelitian ini hanya
akan dipergunakan untuk kepentingan pendidikan serta pengembangan ilmu pengetahuan.
Demikian surat persetujuan ini saya terima setelah mendapat penjelasan
mengenai maksud dan tujuan penelitian tanpa paksaan atau tekanan.
Pati,
Peneliti,
( Reza Rachman )
2016
Subjek Penelitian,
(
)
116
Lampiran 5. Kuesioner Penelitian
KUESIONER PENELITIAN
“Faktor Risiko Kejadian Hipertensi pada Pasien di Poliklinik RSUD RAA
Soewondo Kabupaten Pati”
Keterangan Responden (di isi oleh pasien)
1. Nomor
:
2. Tanggal pemeriksaan
:
3. Hasil pengukuran tekanan darah
:
4. Hasil pengukuran tinggi badan
:
5. Hasil pengukuran berat badan
:
6. BMI =
:
Identitas Responden
1. Nama
:
2. Alamat
:
3. Umur
:
4. Jenis kelamin :
5. Pendidikan
:
6. Pekerjaan
:
117
No. Pertanyaan
1.
Sejak
Jawaban
kapan
anda
didiagnosis
menderita hipertensi atau darah
tinggi?
2.
3.
Apakah anda memiliki riwayat
1. Ya
keluarga menderita hipertensi?
2. Tidak
Seberapa
banyak
mengkonsumsi
perhari
anda
garam
sebelum
dapur
menderita
hipertensi?
4.
banyak
mengkonsumsi
anda
garam
setelah
dapur
menderita
Seberapa
2. Jarang, jika konsumsi garam
1. Sering, jika konsumsi garam
≥1 sendok teh per hari.
2. Jarang, jika konsumsi garam
3 kali
sesudah menderita hipertensi?
dalam seminggu.
2. Jarang, jika ≤3 kali seminggu
mengkonsumsi
makanan
berlemak dan / atau gorengan
7.
8.
Apakah anda memiliki kebiasaan
1. Ya
merokok ?
2. Tidak
Apakah anda memiliki kebiasaan
mengkonsumsi alkohol ?
1. Ya
118
2. Tidak
9.
Seberapa
banyak
mengkonsumsi alkohol
anda
1. Iya, saya memiliki kebiasaan
sebelum
mengkonsumsi alkohol ≥ 2
menderita hipertensi?
gelas perhari.
2. Iya, saya memiliki kebiasaan
mengkonsumsi alkohol < 2
gelas perhari.
10.
Seberapa
banyak
mengkonsumsi
alkohol
anda
1. Iya, saya memiliki kebiasaan
setelah
mengkonsumsi alkohol ≥ 2
menderita hipertensi?
gelas perhari.
2. Iya, saya memiliki kebiasaan
mengkonsumsi alkohol < 2
gelas perhari.
11.
Apakah anda melakukan olahraga
1. Saya
melakukan
secara teratur sebelum menderita
tertentu
seminggu
hipertensi?
dengan
waktu
olahraga
3
kali
sekitar
30
menit.
2. Saya tidak pernah melakukan
kegiatan
olahraga
secara
teratur.
12.
Apakah anda melakukan olahraga
1. Saya
melakukan
secara teratur sebelum menderita
tertentu
seminggu
hipertensi?
dengan
waktu
olahraga
3
kali
sekitar
30
menit.
2. Saya tidak pernah melakukan
kegiatan
olahraga
secara
teratur.
13.
Apakah
anda
saat
ini
1. Ya, saat ini saya sedang
mengkonsumsi obat anti hipertensi
mengkonsumsi
?
hipertensi.
obat
anti
119
2. Tidak, saat ini saya tidak
sedang mengkonsumsi obat
anti hipertensi.
14.
Berapa macam jumlah obat anti
hipertensi yang anda konsumsi saat
ini ?
1. Saat ini mengkonsumsi 1 jenis
obat anti hipertensi.
2. Saat ini mengkonsumsi >1
jenis obat hipertensi.
15.
Apakah anda tahu bahwa hipertensi
1. Tidak tahu
adalah
2. Tahu
faktor
risiko
penyakit
jantung koroner ?
16.
Apakah anda pernah memeriksakan
1. Pernah
faktor
2. Belum pernah
risiko
penyakit
jantung
koroner yang lain, seperti DM dan
kolestrol tinggi ?
17.
Bagaimana
hasil
faktor risiko tersebut ?
pemeriksaan
1. Ada kelainan, dengan
2. Tidak ada kelainan
120
Lampiran 6. Surat Perijinan Penelitian
121
Lampiran 7. Surat Telah Melakukan Penelitian
122
Lampiran 8. Ethical Clearence
123
124
Lampiran 9. Biodata Mahasiswa
Identitas
Nama
: Reza Rachman
NIM
: 22010112110033
Tempat / tanggal lahir
: Pati, 6 Desember 1993
Jenis kelamin
: Laki - laki
Alamat
: Jalan Mediatama E 11 Perumahan Taman Setiabudi
Banyumanik, Semarang
Nomor HP
: 0811270281
E-mail
: [email protected]
Riwayat Pendidikan Formal
1. SD
: 2000 Lulus tahun : 2006
2. SMP
: 2006 Lulus tahun : 2009
3. SMA
: 2009 Lulus tahun : 2012
4. FK UNDIP Masuk tahun 2012
Keanggotaan Organisasi
1. Staf SENIOR HIMA KU 2012/2013
Pengalaman penelitian
1. Judul : Faktor Risiko Kejadian Hipertensi pada Pasien yang Berobat di Poliklinik
RSUD RAA Soewondo Pati.
1. G.K. Gupta, Agrawal Deepika , R.K. Arya, Prevalence risk factors and socio
demographic co – relates of adolescent hypertension in district
Ghaziabad.Indian Journal of community Health [internet]. c2013 [cited 2016
Jan 20]: 25(3):296-301. Available from: http://www.iapsmupuk.org/journal.
2. WHO. Non Communicable Disease: Hypertension [internet]. c2011 [cited
2015 Nov 11]. Available from: http://www.searo.who.int/.
3. Balitbang Kemenkes RI. Riset Kesehatan Dasar; RISKESDAS. Jakarta:
Balitbang Kemenkes RI; 2013.
4. RSUD RAA Soewondo. Profil RSUD RAA. Soewondo Pati Tahun 2014.
Pati: RSUD RAA Soewondo; 2014.
5. RSUD RAA Soewondo. 2014. Profil RSUD RAA. Soewondo Pati Tahun
2012. Pati: RSUD RAA Soewondo; 2014.
6. RSUD RAA Soewondo. Profil RSUD RAA. Soewondo Pati Tahun 2013.
Pati: RSUD RAA Soewondo; 2014.
7. Babatsikou F, Zavitsanou A. Epidemiology of hypertension in the eldery.
Health Sciene Journal [internet]. c2004 [cited 2015 dec 11] 4(10): 24-30.
Available from : http://www.hsj.gr/medicine/
8. Kim K, Kim YM, Kim EK. Correlation Between the Activities of Daily
Living of Stroke Patients in a Community Setting and Their Quality of Life.
Journal of Physical Therapy Science [internet]. c2014; 26 (3): 417-9.
Available from: http://www.ncbi.nlm.nih.gov
9. Anggraini, dkk. Faktor-faktor yang Berhubungan dengan Kejadian Hipertensi
pada Pasien yang Berobat di Poliklinik Dewasa Puskesmas Bangkinang
Periode Januari sampai Juni 2008 [internet]. c2009 [cited 2015 Nov 25].
Available from: http://yayanakhyar.files.wordpress.com/2009/
10. Chataut J, Adhikari RK, Sinha NP. Prevalence and Risk Factor for
Hypertension in Adults Living in Central Development Region in
Nepal.Kathmandu University Medical Journal [internet]. c2011 [cited 2015
Nov 25] 9(1):13-8. Available from: www.ncbi.com
82
83
11. Kartikasari. Faktor Risiko Hipertensi Pada Masyarakat di Desa Kabongan
Kidul, Kabupaten Rembang [Skripsi] Semarang: Universitas Diponegoro;
2012.
12. Achmad Choirun Ni’am, Berapa Faktor Resiko yang Berhubungan dengan
Kejadian Hipertensi,[Skripsi] Semarang; Universitas Muhammadiyah
Smearang; 2010.
13. Eva Puspita, dkk. Faktor Risiko Kejadian Hipertensi Pada Pasien yang
Berobat di Poliklinik Rumah Sakit Umum Daerah Labuang Baji
Makasar.Jurnal Ilmiah Kesehatan Diagnosis [internet]. c2014 [cited 2015
Nov 25]: 5(1):59-64.Available from: http:// library.stikesnh.ac.id
14. Charbel El Bcheraoui, Ziad A. Memish, Marwa Tuffaha, et al., Hypertension
and Its Associated Risk Factors in the Kingdom of Saudi Arabia, 2013: A
National Survey. International Journal of Hypertension [internet]. c2014
[cited
2015
Nov
25]:
2014(3);1-8.Available
from
:
www.hindawi.com/journals/
15. Syer Ree Tee dkk The Prevalence Of Hypertension And Its Associated Risk
Factors In Two Rural Communities In Penang, Malaysi.International eJournal of Science,Medicine dan education [internet]. c2010 [cited 2015 Nov
22]: 9(3):1-27. Available from : http://web.imu.edu.my/ejournal
16. Q Wei, J Sun, dkk. Prevalence of hypertension and associated risk factors in
Dehui City of Jilin Province in China.Journal of Human Hypertension
[internet]. c2015 [cited 2015 Nov 22]: 32(29), 64–8. Available from :
http://www.nature.com/jhh/journal
17. Reddy S S, Prabhu G R. Prevalence and Risk Factors of Hypertension in
Adults in an Urban Slum, Tirupati, A.P. Indian J Community Med [internet].
c2005 [cited 2016 Jan 20]: 30(3):84-6. Available from :
http://www.ijcm.org.in
18. Sathya Prakash Manimunda, dkk. Association of hypertension with risk
factors & hypertension related behaviour among the aboriginal Nicobarese
tribe living in Car Nicobar Island, Indi. Indian J Med Res [internet]. c2011
[cited 2016 Jan 20] ;133(3): 287–93. Available from :
http://www.ncbi.nlm.nih.gov
19. Gupta G.K, dkk. Prevalence risk factors and socio demographic co – relates
of adolescent hypertension in district Ghaziabad.Indian Journal of community
Health [internet]. c2013 [cited 2016 Jan 20]: 25(3):296-301. Available from :
https://doaj.org/toc/2248-9509/25/3
20. Mukhtar Z. Perubahan Hemodinamik dan Terapi Hipertensi dari Aspek
Kardiovaskuler. 1996. Jakarta: Bamboedoea. p: 24-5.
84
21. Sheldon G. Sheps. Mayo Clinic Hipertension (Terjemahan). Jakarta: Intisari
Mediatama; 2005. p: 26, 158.
22. Siregar TGM. Hipertesi esensial. Dalam: Rilantono et al. (ed). Buku ajar
kardiologi. 2003. Jakarta: FKUI
23. Yogiantoro M. Hipertensi Esensial. Dalam: Sudoyo et al. (ed). Buku ajar ilmu
penyakit dalam. Jilid I edisi IV. Jakarta: FKUI; 2006. p: 610-14.
24. Sheps SG. Mayo Clinic Hipertension (Terjemahan). Jakarta: Intisari
Mediatama; 2005. p: 26, 158.
25. Dharmeizar. Hipertensi. Medicinus Scientific Journal of Pharmacheutical
Development and Medical Application [internet]. c2012 [cited 2016 Jan 14].
25(10):5-6. Available from : http://www.dexa-medica.com
26. Andrea. Korelasi Derajat Hipertensi dengan Stadium Penyakit Ginjal Kronik
Di RSUP DR Kariadi periode 2008 - 2012 [Skripsi] Semarang: Universitas
Diponegoro; 2013.
27. Sari AAP, Kristiana IGAAW, dan Ayu NLPM. Gambaran Faktor-faktor
Determinan pada Pasien Hipertensi di Desa Sudimara Kecamatan Tabanan,
Kabupaten Tabanan Mei 2010 [internet]. c2010 [cited 2015 Nov 27]. p: 8.
Available from: http:// dc252.4shared.com/doc/
28. Martin J. Hypertension Guidelines: Revisiting The JNC 7 Recommendations.
The Journal of Lancaster General Hospital [internet]. c2008 [cited 2015 Des
6]: 3 (3):91-7. Available from : http://www.jlgh.org/JLGH/media/Journal
29. Mansjoer A, dkk. Kapita Selekta Kedokteran Jilid I: Nefrologi dan
Hipertensi. Jakarta: Media Aesculapius FK UI; 2001. p: 519-20.
30. Klasifikasi Hipertensi [internet]. c2009 Sep 14 [cited 2015 Nov 27].
Available from: http://www.dokter-medis.blogspot.com/
31. Kaplan NM. Primary Hipertension: pathogenesis. Kaplan’s clinical
Hypertension. 10th edition. Philadelphia: Lippincot Williams & Wilkins;
2010. p. 44-108.
32. Klabunde R. Cardiovascular Physiologi Concept. Philadelphia: Lippincot
Williams & Wilkins; 2005.
33. Lopez-Sendon J, Swedenberg K, Mcmurray J, et al. Expert consensus
document on b-adrenergic receptor blocker: The Task Force on Beta-Blocker
of the European Society of Cardioligy. Eur Heart J. 2004; 25:1341-62.
85
34. de Groot AA, Mathy MJ, van Zwieten PA, et al. Involvement of the B3
Adrenoreceptor in Nebivolol-Induced Vasorelaxtion in Rat Aorta. J
Cardiovasc Pharmacol. 2003; 42:232-60.
35. Dzau VJ, Braundwald E, Resolved and unresolved issue in the prevention and
treatment of coronary artery disease: a workshop consensus steatment. Am
Heart J. 1991; 121:1244-63
36. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modiable risk
factor assosiated with myocardial infraction in 52 countries (the
INTERHEART study): case-control study. Lancet. 2004; 364:937-52.
37. Victor RG, Pathophysiology of Target-Organ Disease: Dose Angiotensin II
Remain The Key. J Clin Hypertension. 2007; 9(11): S4
38. Dzau VJ, Antman EM, Black HR, et al. The cardiovascular Disease
Continuum Validated: Clinical Evidence of Improved Patient Outcome.
Circulation. 2006; 114:2850-70.
39. Bonetti PO, Lerman LO, Lerman A. Endotelial Dysfungtion: A marker of
Atherosklerotic Risk. Arterioscler Thtomb Vasc Biol. 2003; 23:168-75.
40. Willerson JT, Kereiakes DJ. Endotelial dysfungtion. Circulation 2003; 108:
2060-1.
41. Strawn WB, Ferrario CM. Mechanism linking Angiotensin II and
Atherogenesis, Curr Opin Lipidol. 2002; 13:505-52.
42. Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Suzuki Y, Mezzano S,
Plaza JJ, Egido J. Role of the Renin Angiotensin System in Vasculare
Disease: Expending the Field. Hyperthension. 2001; 38: 1382.
43. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, dkk.
Hope study Investigators. Albuminuria and risk of cardiovascular events,
death, and heart failure in diabetic and non diabetic individuals. JAMA. 2001;
286: 421-6.
44. Lindholm LH, Ibsen H, Dahlof B, dkk. Cardiovaskular morbidity and
mortality in patients with diabetes in the Losartan Intervention for Endpoint
reduction in hypertension study (LIFE): a randomized trial against atenolol.
Lancet. 2002; 359:1004-10.
45. Hanifa A. Prevalensi Hipertensi Sebagai Penyebab Penyakit Ginjal Kronik Di
Unit Hemodialisis RSUP H.Adam Malik Medan Tahun 2009 [internet].
c2010
[cited
2015
Nov
27].
p:
4-13.
Available
from:
http://repository.usu.ac.id/
86
46. Sugiarto A. Faktor-faktor Risiko Hipertensi Grade II pada Masyarakat (Studi
Kasus di Kabupaten Karanganyar) [internet]. c2007 [cited 2015 Nov 27]. p:
29-50, 90-126. Available from: http://eprints.undip.ac.id/
47. Faktor Risiko Hipertensi yang Tidak dapat Dikontrol [internet]. c2011 [cited
2015 Nov 22]. Available from: http://smallcrab.com/kesehatan/
48. Nurkhalida. Warta Kesehatan Masyarakat. Jakarta : Depkes RI; 2003. p: 1921.
49. Lam Murni BR Sagala. Perawatan Penderita Hipertensi di Rumah oleh
Keluarga Suku Batak dan Suku Jawa di Kelurahan Lau Cimba Kabanjahe
[internet]. c2011 [cited 2015 Dec 4]. p: 10-13. Available from:
http://repository.usu.ac.id/
50. Sandhya Pruthi. Menopause and High Blood Pressure [internet]. c2010 [cited
2011 Nov 26]. Available from: http://www.mayoclinic.com/health/
51. Soetjiningsih. Tumbung kembang remaja dan permasalahannya. Jakarta:
Sagung Seto; 2004. p. 77-86.
52. Festy. Hubungan perilaku orang tua dengan kejadian obesitas pada anak prasekolah (3-5 tahun) di Taman Flora kota Surabaya. Jurnal Penelitian Akademi
Kesehatan Rajekwesi Bojonegoro [internet]. c2012 [cited 2015 Dec 12]; 6(3):
22-6. Available from : https://jurnalakesrajekwesi.files
53. Anggara FHD, Prayitno N. Faktor-Faktor Yang Berhubungan dengan
Tekanan Darah di Puskesmas Telaga Murni, Cikarang Barat Tahun 2012.
Jurnal Ilmiah Kesehatan [internet]. c2013 [cited 2015 Dec 13]: 5(1):20-5.
Available from : http://lp3m.thamrin.ac.id
54. Natalia D, Hasibuan P, Hendro. Hubungan Obesitas dengan Kejadian
Hipertensi di Kecamatan Sintang, Kalimantan Barat. eJKI [internet]. c2014;
2(3):156-8. Available from : http://www.kalbemed.com/
55. Setyanda O, Sulastri D, Lestari Y. Hubungan Merokok dengan Kejadian
Hipertensi pada Laki-Laki Usia 35-65 Tahun di Kota Padang. Jurnal
Kesehatan andalas [internet]. c2015 [cited 2016 Jan 18]: 4(2): 434-9.
Available from : http://jurnal.fk.unand.ac.id.
56. Departemen Kesehatan Republik Indonesia. Pedoman Teknis Penemuan dan
Tatalaksana Penyakit Hipertensi. Jakarta: Departemen Kesehatan Republik
Indonesia; 2008. p. 14–28.
87
57. Departemen Kesehatan Republik Indonesia. Pedoman Surveilans Penyakit
Jantung dan Pembuluh Darah. Jakarta: Departemen Kesehatan Republik
Indonesia; 2008. p. 6.
58. Sherwood L. Pembuluh Darah dan Tekanan Darah. Dalam: Fisologi Manusia
dari Sel ke Sistem. Edisi 2. Jakarta: EGC; 2011. p.335–6.
59. Mukamal KJ. The Effects of Smoking on Cardiovascular Desease. Boston:
Departement of Interna Harvard Medical School; 2006. p.199.
60. Aris Sugiarto. Faktor–Faktor Risiko Hipertensi Grade II pada Masyarakat
(Studi Kasus di Kabupaten Karang Anyar) [internet]. c2007 [cited 2015 Dec
15]. p: 22-24, 77 – 79. Available from : http://eperintis.undip.ac.id/
61. National Institutes of Health. The Seventh Report of the Joint National
Committee on Prevention, Detection Evaluation, and Treatment of High
Blood Pressure, Atlanta: U. S. Department of Health and Human Services;
2004. p.31-5.
62. Brown C. Penyakit Aterosklerotik. Dalam: Price A, Wilson LM. Konsep
Klinis Proses–Proses Penyakit. Volume 1. Edisi 6. Jakarta: EGC; 2006. p.
582–7.
63. Kevin JW, John D. Nondrug Interventions for Treatment of Hypertension.
New York: Division of Cardiology University of Rochester Medical Center;
2011. p.231-89.
64. Dharmeizar. Hipertensi. Medicinus Scientific Journal of Pharmacheutical
Development and Medical Application [internet]. c2012 [cited 2016 Jan 14].
25(10):3-8. Available from : http://www.dexa-medica.com
65. Sartika, RAD. Pengaruh Lemak Trans Terhadap Kesehatan Jantung,
MAKARA Jurnal Sains [internet]. c2009 [cited 2016 Jan 10]; 13(1): 23-8.
Available from : http://jurnalkesmas.ui.ac.id
66. Shapo L, Pomerleau J, McKee M. Epidemiology of Hypertension and
Associated Cardiovascular Risk Factors in a Country in Transition. Journal
Epidemiology Community Health [internet]. c2003 [cited 2016 Jan 10];
57:734–9. Available from : http://www.ncbi.nlm.nih.gov\
67. Widyaningrum A T. Hubungan Asupan Natrium, Kalium, Magnesium dan
Status gizi dengan Tekanan Darah pada Lansia di Kalurahan Makamhaji
Kecamatan Kartasura. [internet]. c2014 [cited 2016 Jan 19]. p: 1-6. Available
from : http://eprints.ums.ac.id
88
68. Wijayanti E. Asupan Natrium dari Makanan Jajanan dan Tekanan Darah
Siswa Sekolah Dasar Studi di SD Negeri 06 Petompon. [internet]. c2010
[cited 2016 Jan 13]. p: 1. Available from : http://eprints.undip.ac.id
69. Bustan, MN. Epidemiologi penyakit menular, Jakarta: Rineka Cipta; 2007.
70. Komaling, JK, Suba, B, Wongkar, D. Hubungan Mengonsumsi Alkohol
dengan Kejadian Hipertensi pada Laki-laki Di Desa Tompasobaru II
Kecamatan Tompasobaru Kabupaten Minahasa Selatan. e-KP [internet].
c2013 [cited Jan 11]: 1(1): 25-30.
71. Susalit E, Kapojos EJ, Lubis HR. Hipertensi Primer Dalam Buku Ajar Ilmu
Penyakit Dalam, Edisi III, Jilid II, Jakarta: Balai Penerbit FKUI. 2001. p.45372.
72. Ganiswara. Farmakologi dan Terapan. Edisi IV. Jakarta: Bagian Farmakologi
FKUI; 1995. p. 317.
73. Yogiantoro, M. Hipertensi Esensial. Jakarta: Departemen Ilmu Penyakit
Dalam FKUI; 2006. p: 599-601.
74. Susalit E, Kapojos EJ, Lubis HR. Hipertensi Primer. Dalam: Buku Ajar Ilmu
Penyakit Dalam, Edisi III, Jilid II, Jakarta: Balai Penerbit FKUI. p. 453-70.
75. Mannan, H, Wahiduddin, Rismayanti. Faktor Risiko Kejadian Hipertensi di
Wilayah Kerja Puskesmas Bangkala Kabupaten Jeneponto Tahun 2011
Makassar [internet]. c2013 [cited 2016 April 18]. Available from:
http://repository.unhas.ac.id
76. Liu J, Sekine M, Tatsuse T, et al. Family history of hypertension and the risk
of overweight in Japanese children: results from the Toyama Birth Cohort
Study J Epidemiol [internet]. c2014 [cited 2016 Apr 18] 24(4):304–11.
Available from : http://www.ncbi.nlm.nih.gov/pubmed/24857956
77. Kumar V, Abbas AK, Fausto and, Hypertensive Vascular Disease. Dalam :
Robn and Cotran Pathologic basis of disease. Edisi 7. Philadeltia: Elsevier
Saunders, 2005. p. 528 – 9.
78. Pang W dkk. Prevalence of Hypertension and Associated Factors Among
Older Rural Adults: Results from Liaoning Province, China. Med Princ Pract
[internet]. c2010 [cited 2016 Apr 22]: 19(1):22–27. Available from :
http://dx.doi.org/10.1159/000252830
89
79. Niskanen L, dkk. Inflammation, abdominal obesity, and smoking as
predictors of hypertension. Hypertension [internet]. c2004 [cited 2016 Apr
24]:
44(6):859–865.
Available
from
:
http://dx.doi.org/10.1161/01.HYP.0000146691.51307.84
80. Bowman ST et al. Clinical research Hypertension. A Prospective Study of
Cigarette Smokey And Risk of Inciden Hypertension In Bringham and
women Hospital Massachucettes [internet]. c2007 [cited 2016 Apr 25] :
50(21):2085-92. Available from: www.ncbi.nlm.nih.gov/pubmed/18021879
81. Stritzke J, Markus MP, Duderstadt S. Obesity is The Main Risk factor for
Left Atrial Enlargement during Aging. The MONICA/KORA (Monitoring of
Trends and Determinations in Cardiovascular Disease/Cooperative Research
in the Region of Augsburg) Study. J Am Coll Cardiol [internet]. c2009 Nov
[cited 2016 Apr 29]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/
82. Rahyani F. Epidemiologi Penderita Hipertensi Esensial yang Dirawat di
Bagian Penyakit Dalam Perjan RS DR. M. Djamil Padang Periode 1 Januari
2002 -31 Desember 2003. Skripsi. Padang. 2005. Hal 32
83. Ball CO, Meneely GR. Observations on Dietary Sodium Chloride. J Am Diet
Assoc [internet]. c1957 [cited 2016 Apr 29 ]: 33(4):366–370. Available from
: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4105387/
84. Denton D, Weisinger R, Mundy Ni, Wickings EJ dkk. The Effect of Increased
Salt Intake on Blood Pressure of Chimpanzees. Nat Med [internet] c1995
[cited 2016 May 4]:
1(10):
1009-16. Available from
:
http://www.ncbi.nlm.nih.gov/pubmed/7489355
85. Fukui M, Tanaka M, Toda H, Senmaru T, Sakabe K, Ushigome E, Nakamura
N. Risk Factors for Development of Diabetes Mellitus, Hypertension and
Dyslipidemia. Diabetes Res Clin Pract [internet] c2011 [cited 2016 May 10].
Available from : http://dx.doi.org/10.1016/j.diabres.2011.07.006 .
86. Halperin R. O., Sesso H. D., Ma J, Buring J. E., Stampfer M. J., Gaziano J.
M. Dyslipidemia and The Risk of Incident Hypertension in Men.
Hypertension. AHA Journal [internet] c2006 [cited 2016 May 7]:47(1):45–
50. Available from : http://dx.doi.org/10.1161/01.HYP.0000196306.42418.0e
.
87. Howard DS, Nancy RC, Julie EB, JoAnn EM, Michael G. Alcohol
Consumption and the Risk of Hypertension in Women and Men.
Hypertension [internet] c2008 [cited 2016 May 7]:51(4):1080-7. Available
from : http://www.ncbi.nlm.nih.gov/pubmed/18259032
90
Lampiran 1. Analisis Univariat Beberapa Variabel Bebas Terhadap Kondisi Tekanan
Darah Subjek dengan Menggunakan Uji Chi Aquare Program SPSS
Frequency Table
Umur
Valid
>= 55
< 55
Total
Frequency
42
33
75
Perc ent
56.0
44.0
100.0
Valid Percent
56.0
44.0
100.0
Cumulative
Perc ent
56.0
100.0
Jenis Kelamin
Valid
Laki-laki
Perempuan
Total
Frequency
31
44
75
Perc ent
41.3
58.7
100.0
Valid Percent
41.3
58.7
100.0
Cumulative
Perc ent
41.3
100.0
Pendidikan
Valid
Dasar
Menengah/Tinggi
Total
Frequency
38
37
75
Perc ent
50.7
49.3
100.0
Valid Percent
50.7
49.3
100.0
Cumulative
Perc ent
50.7
100.0
91
Pekerjaan
Valid
Tidak bekerja
Buruh
Swasta
Wiraswasta
PNS/POLRI/TNI
Pensiunan
Total
Frequency
19
11
11
2
23
9
75
Percent
25.3
14.7
14.7
2.7
30.7
12.0
100.0
Valid Percent
25.3
14.7
14.7
2.7
30.7
12.0
100.0
Cumulative
Percent
25.3
40.0
54.7
57.3
88.0
100.0
Tekanan Darah
Valid
Hipertensi II
Hipertensi I
Total
Frequency
49
26
75
Perc ent
65.3
34.7
100.0
Valid Percent
65.3
34.7
100.0
Cumulative
Perc ent
65.3
100.0
BMI
Valid
Obese
Non Obese
Total
Frequency
47
28
75
Perc ent
62.7
37.3
100.0
Valid Percent
62.7
37.3
100.0
Cumulative
Perc ent
62.7
100.0
Riw. Keluarga Hipertensi
Valid
Ya
Tidak
Total
Frequency
49
26
75
Perc ent
65.3
34.7
100.0
Valid Percent
65.3
34.7
100.0
Cumulative
Perc ent
65.3
100.0
92
Konsumsi Garam
Valid
Sering
Jarang
Total
Frequency
70
5
75
Percent
93.3
6.7
100.0
Valid Percent
93.3
6.7
100.0
Cumulative
Percent
93.3
100.0
Konsumsi Lemak
Valid
Sering
Jarang
Total
Frequency
72
3
75
Percent
96.0
4.0
100.0
Valid Percent
96.0
4.0
100.0
Cumulative
Percent
96.0
100.0
Kebiasan Merokok
Valid
Ya
Tidak
Total
Frequency
17
58
75
Perc ent
22.7
77.3
100.0
Valid Percent
22.7
77.3
100.0
Cumulative
Perc ent
22.7
100.0
Konsumsi Alkohol
Valid
Ya
Tidak
Total
Frequency
4
71
75
Perc ent
5.3
94.7
100.0
Valid Percent
5.3
94.7
100.0
Cumulative
Perc ent
5.3
100.0
93
Olah raga teratur
Valid
Tidak
Ya
Total
Frequency
40
35
75
Perc ent
53.3
46.7
100.0
Valid Percent
53.3
46.7
100.0
Cumulative
Perc ent
53.3
100.0
94
Lampiran 2. Analisis Bivariat Beberapa Variabel Bebas Terhadap Kondisi Tekanan
Darah Subjek dengan Menggunakan Uji Chi Aquare Program SPSS
Umur * Tekanan Darah
Crosstab
Umur
>= 55
< 55
Total
Count
Expec ted Count
% within Tekanan Darah
Count
Expec ted Count
% within Tekanan Darah
Count
Expec ted Count
% within Tekanan Darah
Tekanan Darah
Hipertensi II Hipertensi I
27
15
27.4
14.6
55.1%
57.7%
22
11
21.6
11.4
44.9%
42.3%
49
26
49.0
26.0
100.0%
100.0%
Total
42
42.0
56.0%
33
33.0
44.0%
75
75.0
100.0%
Chi-Square Tests
Pearson Chi-Square
Continuity Correc tiona
Likelihood Ratio
Fisher's Exact Tes t
Linear-by-Linear
Association
N of Valid Cases
Value
.046b
.000
.046
.046
df
1
1
1
1
Asymp. Sig.
(2-sided)
.830
1.000
.830
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
1.000
.513
.831
75
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is 11.
44.
95
Symmetric Measures
Nominal by Nominal
N of Valid Cases
Contingency Coefficient
Value
.025
75
Approx. Sig.
.830
a. Not ass uming the null hypothesis.
b. Using the asymptotic standard error assuming the null hypothesis.
Risk Estimate
Value
Odds Ratio for Umur
(>= 55 / < 55)
For cohort Tekanan
Darah = Hipertensi II
For cohort Tekanan
Darah = Hipertensi I
N of Valid Cases
95% Confidence
Interval
Lower
Upper
.900
.344
2.351
.964
.693
1.342
1.071
.570
2.013
75
Jenis Kelamin * Tekanan Darah
Crosstab
Jenis Kelamin
Laki-laki
Perempuan
Total
Count
Expec ted Count
% within Tekanan Darah
Count
Expec ted Count
% within Tekanan Darah
Count
Expec ted Count
% within Tekanan Darah
Tekanan Darah
Hipertensi II Hipertensi I
21
10
20.3
10.7
42.9%
38.5%
28
16
28.7
15.3
57.1%
61.5%
49
26
49.0
26.0
100.0%
100.0%
Total
31
31.0
41.3%
44
44.0
58.7%
75
75.0
100.0%
96
Chi-Square Tests
Pearson Chi-Square
Continuity Correc tiona
Likelihood Ratio
Fisher's Exact Tes t
Linear-by-Linear
Association
N of Valid Cases
Value
.135b
.015
.136
.134
df
1
1
1
Asymp. Sig.
(2-sided)
.713
.903
.712
1
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
.808
.453
.715
75
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is 10.
75.
Symmetric Measures
Nominal by Nominal
N of Valid Cases
Contingency Coefficient
Value
.042
75
Approx. Sig.
.713
a. Not ass uming the null hypothesis.
b. Using the asymptotic standard error assuming the null hypothesis.
Risk Estimate
Value
Odds Ratio for Jenis
Kelamin (Laki-laki /
Perempuan)
For cohort Tekanan
Darah = Hipertensi II
For cohort Tekanan
Darah = Hipertensi I
N of Valid Cases
95% Confidence
Interval
Lower
Upper
1.200
.454
3.171
1.065
.765
1.481
.887
.467
1.687
75
97
Pendidikan * Tekanan Darah
Crosstab
Pendidikan
Dasar
Menengah/Tinggi
Total
Count
Expec ted Count
% within Tekanan Darah
Count
Expec ted Count
% within Tekanan Darah
Count
Expec ted Count
% within Tekanan Darah
Tekanan Darah
Hipertensi II Hipertensi I
24
14
24.8
13.2
49.0%
53.8%
25
12
24.2
12.8
51.0%
46.2%
49
26
49.0
26.0
100.0%
100.0%
Total
38
38.0
50.7%
37
37.0
49.3%
75
75.0
100.0%
Chi-Square Tests
Pearson Chi-Square
Continuity Correc tiona
Likelihood Ratio
Fisher's Exact Tes t
Linear-by-Linear
Association
N of Valid Cases
Value
.161b
.025
.161
.159
df
1
1
1
1
Asymp. Sig.
(2-sided)
.688
.874
.688
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
.809
.437
.690
75
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is 12.
83.
Symmetric Measures
Nominal by Nominal
N of Valid Cases
Contingency Coefficient
Value
.046
75
Approx. Sig.
.688
a. Not ass uming the null hypothesis.
b. Using the asymptotic standard error assuming the null hypothesis.
98
Risk Estimate
Value
Odds Ratio for
Pendidikan (Dasar /
Menengah/Tinggi)
For cohort Tekanan
Darah = Hipertensi II
For cohort Tekanan
Darah = Hipertensi I
N of Valid Cases
95% Confidence
Interval
Lower
Upper
.823
.317
2.134
.935
.672
1.300
1.136
.609
2.121
75
Pekerjaan * Tekanan Darah
Crosstab
Pekerjaan
Tidak bekerja
Buruh
Swasta
Wiraswasta
PNS/POLRI/TNI
Pensiunan
Total
Count
Expec ted Count
% within Tekanan Darah
Count
Expec ted Count
% within Tekanan Darah
Count
Expec ted Count
% within Tekanan Darah
Count
Expec ted Count
% within Tekanan Darah
Count
Expec ted Count
% within Tekanan Darah
Count
Expec ted Count
% within Tekanan Darah
Count
Expec ted Count
% within Tekanan Darah
Tekanan Darah
Hipertensi II Hipertensi I
10
9
12.4
6.6
20.4%
34.6%
6
5
7.2
3.8
12.2%
19.2%
10
1
7.2
3.8
20.4%
3.8%
1
1
1.3
.7
2.0%
3.8%
16
7
15.0
8.0
32.7%
26.9%
6
3
5.9
3.1
12.2%
11.5%
49
26
49.0
26.0
100.0%
100.0%
Total
19
19.0
25.3%
11
11.0
14.7%
11
11.0
14.7%
2
2.0
2.7%
23
23.0
30.7%
9
9.0
12.0%
75
75.0
100.0%
99
Chi-Square Tests
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Assoc iation
N of Valid Cases
Value
5.492a
6.160
1.106
5
5
Asymp. Sig.
(2-sided)
.359
.291
1
.293
df
75
a. 5 cells (41.7%) have expected count less than 5. The
minimum expected count is .69.
Symmetric Measures
Nominal by Nominal
N of Valid Cases
Contingency Coefficient
Value
.261
75
Approx. Sig.
.359
a. Not ass uming the null hypothesis.
b. Using the asymptotic standard error assuming the null hypothesis.
BMI * Tekanan Darah
Crosstab
BMI
Obese
Non Obese
Total
Count
Expec ted Count
% within Tekanan Darah
Count
Expec ted Count
% within Tekanan Darah
Count
Expec ted Count
% within Tekanan Darah
Tekanan Darah
Hipertensi II Hipertensi I
33
14
30.7
16.3
67.3%
53.8%
16
12
18.3
9.7
32.7%
46.2%
49
26
49.0
26.0
100.0%
100.0%
Total
47
47.0
62.7%
28
28.0
37.3%
75
75.0
100.0%
100
Chi-Square Tests
Pearson Chi-Square
Continuity Correc tiona
Likelihood Ratio
Fisher's Exact Tes t
Linear-by-Linear
Association
N of Valid Cases
Value
1.323b
.809
1.310
1.306
df
1
1
1
1
Asymp. Sig.
(2-sided)
.250
.368
.252
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
.318
.184
.253
75
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is 9.
71.
Symmetric Measures
Nominal by Nominal
N of Valid Cases
Contingency Coefficient
Value
.132
75
Approx. Sig.
.250
a. Not ass uming the null hypothesis.
b. Using the asymptotic standard error assuming the null hypothesis.
Risk Estimate
Value
Odds Ratio for BMI
(Obes e / Non Obese)
For cohort Tekanan
Darah = Hipertensi II
For cohort Tekanan
Darah = Hipertensi I
N of Valid Cases
95% Confidence
Interval
Lower
Upper
1.768
.667
4.688
1.229
.848
1.780
.695
.377
1.283
75
101
Riw. Keluarga Hipertensi * Tekanan Darah
Crosstab
Riw. Keluarga
Hipertensi
Ya
Tidak
Total
Count
Expec ted Count
% within Tekanan Darah
Count
Expec ted Count
% within Tekanan Darah
Count
Expec ted Count
% within Tekanan Darah
Tekanan Darah
Hipertensi II Hipertensi I
33
16
32.0
17.0
67.3%
61.5%
16
10
17.0
9.0
32.7%
38.5%
49
26
49.0
26.0
100.0%
100.0%
Total
49
49.0
65.3%
26
26.0
34.7%
75
75.0
100.0%
Chi-Square Tests
Pearson Chi-Square
Continuity Correc tiona
Likelihood Ratio
Fisher's Exact Tes t
Linear-by-Linear
Association
N of Valid Cases
Value
.253b
.062
.251
.250
df
1
1
1
1
Asymp. Sig.
(2-sided)
.615
.804
.616
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
.621
.399
.617
75
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is 9.
01.
Symmetric Measures
Nominal by Nominal
N of Valid Cases
Contingency Coefficient
Value
.058
75
Approx. Sig.
.615
a. Not ass uming the null hypothesis.
b. Using the asymptotic standard error assuming the null hypothesis.
102
Risk Estimate
Value
Odds Ratio for Riw.
Keluarga Hipertensi
(Ya / Tidak)
For cohort Tekanan
Darah = Hipertensi II
For cohort Tekanan
Darah = Hipertensi I
N of Valid Cases
95% Confidence
Interval
Lower
Upper
1.289
.479
3.470
1.094
.763
1.570
.849
.452
1.596
75
Konsumsi Garam * Tekanan Darah
Crosstab
Konsumsi
Garam
Sering
Jarang
Total
Count
Expec ted Count
% within Tekanan Darah
Count
Expec ted Count
% within Tekanan Darah
Count
Expec ted Count
% within Tekanan Darah
Tekanan Darah
Hipertensi II Hipertensi I
45
25
45.7
24.3
91.8%
96.2%
4
1
3.3
1.7
8.2%
3.8%
49
26
49.0
26.0
100.0%
100.0%
Total
70
70.0
93.3%
5
5.0
6.7%
75
75.0
100.0%
103
Chi-Square Tests
Pearson Chi-Square
Continuity Correc tiona
Likelihood Ratio
Fisher's Exact Tes t
Linear-by-Linear
Association
N of Valid Cases
Value
.509b
.052
.554
Asymp. Sig.
(2-sided)
.476
.820
.457
df
1
1
1
.502
1
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
.653
.430
.479
75
a. Computed only for a 2x2 table
b. 2 cells (50.0%) have expected count les s than 5. The minimum expected count is 1.
73.
Symmetric Measures
Nominal by Nominal
N of Valid Cases
Value
.082
75
Contingency Coefficient
Approx. Sig.
.476
a. Not ass uming the null hypothesis.
b. Using the asymptotic standard error assuming the null hypothesis.
Risk Estimate
Value
Odds Ratio for Konsums i
Garam (Sering / Jarang)
For cohort Tekanan Darah
= Hipertensi II
For cohort Tekanan Darah
= Hipertensi I
N of Valid Cases
95% Confidence
Interval
Lower
Upper
.450
.048
4.249
.804
.501
1.288
1.786
.301
10.600
75
104
Konsumsi Lemak * Tekanan Darah
Crosstab
Konsumsi
Lemak
Sering
Jarang
Total
Count
Expec ted Count
% within Tekanan Darah
Count
Expec ted Count
% within Tekanan Darah
Count
Expec ted Count
% within Tekanan Darah
Tekanan Darah
Hipertensi II Hipertensi I
47
25
47.0
25.0
95.9%
96.2%
2
1
2.0
1.0
4.1%
3.8%
49
26
49.0
26.0
100.0%
100.0%
Total
72
72.0
96.0%
3
3.0
4.0%
75
75.0
100.0%
Chi-Square Tests
Pearson Chi-Square
Continuity Correc tiona
Likelihood Ratio
Fisher's Exact Tes t
Linear-by-Linear
Association
N of Valid Cases
Value
.002b
.000
.002
.002
df
1
1
1
1
Asymp. Sig.
(2-sided)
.960
1.000
.960
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
1.000
.726
.961
75
a. Computed only for a 2x2 table
b. 2 cells (50.0%) have expected count les s than 5. The minimum expected count is 1.
04.
Symmetric Measures
Nominal by Nominal
N of Valid Cases
Contingency Coefficient
Value
.006
75
Approx. Sig.
.960
a. Not ass uming the null hypothesis.
b. Using the asymptotic standard error assuming the null hypothesis.
105
Risk Estimate
Value
Odds Ratio for Konsums i
Lemak (Sering / Jarang)
For cohort Tekanan Darah
= Hipertensi II
For cohort Tekanan Darah
= Hipertensi I
N of Valid Cases
95% Confidence
Interval
Lower
Upper
.940
.081
10.882
.979
.432
2.218
1.042
.204
5.324
75
Kebiasan Merokok * Tekanan Darah
Crosstab
Kebiasan
Merokok
Ya
Tidak
Total
Count
Expec ted Count
% within Tekanan Darah
Count
Expec ted Count
% within Tekanan Darah
Count
Expec ted Count
% within Tekanan Darah
Tekanan Darah
Hipertensi II Hipertensi I
9
8
11.1
5.9
18.4%
30.8%
40
18
37.9
20.1
81.6%
69.2%
49
26
49.0
26.0
100.0%
100.0%
Total
17
17.0
22.7%
58
58.0
77.3%
75
75.0
100.0%
106
Chi-Square Tests
Value
1.490b
.867
1.448
Pearson Chi-Square
Continuity Correc tiona
Likelihood Ratio
Fisher's Exact Tes t
Linear-by-Linear
Association
N of Valid Cases
df
1
1
1
1.471
Asymp. Sig.
(2-sided)
.222
.352
.229
1
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
.255
.175
.225
75
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is 5.
89.
Symmetric Measures
Nominal by Nominal
N of Valid Cases
Contingency Coefficient
Value
.140
75
Approx. Sig.
.222
a. Not ass uming the null hypothesis.
b. Using the asymptotic standard error assuming the null hypothesis.
Risk Estimate
Value
Odds Ratio for Kebiasan
Merokok (Ya / Tidak)
For cohort Tekanan
Darah = Hipertensi II
For cohort Tekanan
Darah = Hipertensi I
N of Valid Cases
95% Confidence
Interval
Lower
Upper
.506
.168
1.525
.768
.475
1.241
1.516
.805
2.857
75
107
Konsumsi Alkohol * Tekanan Darah
Crosstab
Konsumsi
Alkohol
Ya
Tidak
Total
Count
Expected Count
% within Tekanan Darah
Count
Expected Count
% within Tekanan Darah
Count
Expected Count
% within Tekanan Darah
Tekanan Darah
Hipertensi II Hipertensi I
2
2
2.6
1.4
4.1%
7.7%
47
24
46.4
24.6
95.9%
92.3%
49
26
49.0
26.0
100.0%
100.0%
Total
4
4.0
5.3%
71
71.0
94.7%
75
75.0
100.0%
Chi-Square Tests
Pearson Chi-Square
Continuity Correc tiona
Likelihood Ratio
Fisher's Exact Tes t
Linear-by-Linear
Association
N of Valid Cases
Value
.439b
.015
.419
.433
df
1
1
1
1
Asymp. Sig.
(2-sided)
.508
.903
.518
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
.606
.432
.511
75
a. Computed only for a 2x2 table
b. 2 cells (50.0%) have expected count les s than 5. The minimum expected count is 1.
39.
Symmetric Measures
Nominal by Nominal
N of Valid Cases
Contingency Coefficient
Value
.076
75
Approx. Sig.
.508
a. Not ass uming the null hypothesis.
b. Using the asymptotic standard error assuming the null hypothesis.
108
Risk Estimate
Value
Odds Ratio for Konsums i
Alkohol (Ya / Tidak)
For cohort Tekanan Darah
= Hipertensi II
For cohort Tekanan Darah
= Hipertensi I
N of Valid Cases
95% Confidence
Interval
Lower
Upper
.511
.068
3.852
.755
.280
2.041
1.479
.527
4.154
75
Olah raga teratur * Tekanan Darah
Crosstab
Olah raga
teratur
Tidak
Ya
Total
Count
Expec ted Count
% within Tekanan Darah
Count
Expec ted Count
% within Tekanan Darah
Count
Expec ted Count
% within Tekanan Darah
Tekanan Darah
Hipertensi II Hipertensi I
27
13
26.1
13.9
55.1%
50.0%
22
13
22.9
12.1
44.9%
50.0%
49
26
49.0
26.0
100.0%
100.0%
Total
40
40.0
53.3%
35
35.0
46.7%
75
75.0
100.0%
109
Chi-Square Tests
Value
.178b
.032
.178
Pearson Chi-Square
Continuity Correc tiona
Likelihood Ratio
Fisher's Exact Tes t
Linear-by-Linear
Association
N of Valid Cases
.175
df
1
1
1
1
Asymp. Sig.
(2-sided)
.673
.858
.674
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
.809
.429
.675
75
a. Computed only for a 2x2 table
b. 0 cells (.0%) have expected count less than 5. The minimum expected count is 12.
13.
Symmetric Measures
Nominal by Nominal
N of Valid Cases
Contingency Coefficient
Value
.049
75
Approx. Sig.
.673
a. Not ass uming the null hypothesis.
b. Using the asymptotic standard error assuming the null hypothesis.
Risk Estimate
Value
Odds Ratio for Olah
raga teratur (Tidak / Ya)
For cohort Tekanan
Darah = Hipertensi II
For cohort Tekanan
Darah = Hipertensi I
N of Valid Cases
95% Confidence
Interval
Lower
Upper
1.227
.473
3.182
1.074
.769
1.499
.875
.470
1.628
75
110
Lampiran 3. Analisis Multivariat Beberapa Variabel yang Berhubungan dengan Kondisi
Tekanan Darah Subjek dengan Menggunakan Regresi Logistik Berganda Metode
Backward Stepwise (Likelihood Ratio) pada Program SPSS
Logistic Regression
Block 1: Method = Backward Stepwise (Likelihood Ratio)
Variables in the Equation
Step
a
1
Step
a
2
Step
a
3
BMI
Merokok
Obat
Constant
BMI
Obat
Constant
Obat
Constant
B
.723
-.261
1.222
-2.728
.755
1.298
-3.328
1.164
-2.105
S.E.
.533
.615
.605
1.835
.527
.579
1.185
.558
.757
Wald
1.843
.180
4.073
2.211
2.051
5.022
7.890
4.345
7.740
df
1
1
1
1
1
1
1
1
1
Sig.
.175
.672
.044
.137
.152
.025
.005
.037
.005
a. Variable(s) entered on step 1: BMI, Merokok, Obat.
Tabel Karakteristik Data
Variabel
n
%
≥ 55
42
56
< 55
33
44
Laki-laki
31
41,3
Perempuan
44
58,7
Dasar
38
50,7
Menengah/tinggi
37
49,3
Umur
Jenis kelamin
Pendidikan
Pekerjaan
Exp(B)
2.061
.770
3.394
.065
2.127
3.661
.036
3.203
.122
95.0% C.I.for EXP(B)
Lower
Upper
.725
5.854
.231
2.573
1.036
11.118
.757
1.177
5.975
11.392
1.072
9.571
111
Tidak bekerja
19
25,3
Buruh
11
14,7
Swasta
11
14,7
Wiraswasta
2
2,7
PNS/POLRI/TNI
23
30,7
Pensiunan
9
12
Hipertensi II
49
65,3
Hipertensi I
26
34,7
Obese
47
62,7
Non obese
28
37,3
Ya
49
65,3
Tidak
26
34,7
Sering
70
93,3
Jarang
5
6,7
Sering
72
96
Jarang
3
4
Ya
17
22,7
Tidak
58
77,3
Ya
4
5,3
Tidak
71
94,7
Tekanan darah
BMI
Riw. Keluarga hipertensi
Konsumsi garam
Konsumsi lemak
Kebiasaan merokok
Konsumsi alkohol
Olah raga teratur
112
Tidak
40
53,3
Ya
35
46,7
Tabel Hasil Uji Chi Square
Hipertensi
Variabel
II
I
n
%
n
%
≥ 55
27
55,1
15
57,7
< 55
22
44,9
11
42,3
Laki-laki
21
42,9
10
38,5
Perempuan
28
57,1
16
61,5
Dasar
24
49
14
53,8
Menengah/tinggi
25
51
12
46,2
Tidak bekerja
10
20,4
9
34,6
Buruh
6
12,2
5
19,2
Swasta
10
20,4
1
3,8
Wiraswasta
1
2
1
3,8
PNS/POLRI/TNI
16
32,7
7
26,9
Pensiunan
6
12,2
3
11,5
Obese
33
67,3
14
53,8
Non obese
16
32,7
12
46,2
p
r
IK 95%
0,830§
0,025
0,9 (0,34 – 2,35)
0,713§
0,042
1,2 (0,45 – 3,17)
0,688§
0,046
0,82 (0,32 – 2,13)
0,359§
0,261
–
0,250§
0,132
1,77 (0,67 – 4,69)
Umur
Jenis kelamin
Pendidikan
Pekerjaan
BMI
Riw. Keluarga
113
hipertensi
Ya
33
67,3
16
61,5
Tidak
16
32,7
10
38,5
Sering
45
91,8
25
96,2
Jarang
4
8,2
1
3,8
Sering
47
95,9
25
96,2
Jarang
2
4,1
1
3,8
Ya
9
18,4
8
30,8
Tidak
40
81,6
18
69,2
Ya
2
4,1
2
7,7
Tidak
47
95,9
24
92,3
Tidak
27
55,1
13
50
Ya
22
44,9
13
50
0,615§
0,058
1,29 (0,48 – 3,47)
0,653¥
0,082
0,45 (0,05 – 4,25)
1,000¥
0,006
0,94 (0,08 – 10,88)
0,222§
0,140
0,51 (0,17 – 1,53)
0,606¥
0,076
0,51 (0,07 – 3,85)
0,673§
0,049
1,23 (0,47 – 3,18)
Konsumsi garam
Konsumsi lemak
Kebiasaan merokok
Konsumsi alkohol
Olah raga teratur
Ket: * Signifikan; ¥ Fisher’s Exact Test; § Pearson Chi Square
114
Tabel Hasil Uji Regresi Logistik
Step
1
2
3
Variabel
B
p
Ext(B)
IK 95%
0,723
0,175
2,061
0,73 – 5,85
Merokok
-0,261
0,672
0,770
0,23 – 2,57
Konstanta
-2,728
0,137
0,065
0,755
0,152
2,127
Konstanta
-3,328
0,005
0,036
Konstanta
-2,105
0,005
0,122
BMI
BMI
0,76 – 5,98
115
Lampiran 4. Surat Pernyataan Persetujuan (Inform Consent)
Surat Pernyataan Persetujuan sebagai Sampel Penelitian
(Informed Consent)
Saya yang bertanda tangan di bawah ini,
Menyatakan dengan kesungguhannya bahwa saya bersedia untuk menjadi sampel
penelitian mahasiswa S-1 Pendidikan Dokter dengan judul “Faktor Risiko Kejadian
Hipertensi pada Pasien yang Berobat di Poliklinik RSUD RAA Soewondo Pati”, dengan
menjawab setiap pertanyaan yang ada pada kuesioner dengan jujur dan apa adanya.
Informasi yang saudara berikan akan dijaga kerahasiaannya. Penelitian ini hanya
akan dipergunakan untuk kepentingan pendidikan serta pengembangan ilmu pengetahuan.
Demikian surat persetujuan ini saya terima setelah mendapat penjelasan
mengenai maksud dan tujuan penelitian tanpa paksaan atau tekanan.
Pati,
Peneliti,
( Reza Rachman )
2016
Subjek Penelitian,
(
)
116
Lampiran 5. Kuesioner Penelitian
KUESIONER PENELITIAN
“Faktor Risiko Kejadian Hipertensi pada Pasien di Poliklinik RSUD RAA
Soewondo Kabupaten Pati”
Keterangan Responden (di isi oleh pasien)
1. Nomor
:
2. Tanggal pemeriksaan
:
3. Hasil pengukuran tekanan darah
:
4. Hasil pengukuran tinggi badan
:
5. Hasil pengukuran berat badan
:
6. BMI =
:
Identitas Responden
1. Nama
:
2. Alamat
:
3. Umur
:
4. Jenis kelamin :
5. Pendidikan
:
6. Pekerjaan
:
117
No. Pertanyaan
1.
Sejak
Jawaban
kapan
anda
didiagnosis
menderita hipertensi atau darah
tinggi?
2.
3.
Apakah anda memiliki riwayat
1. Ya
keluarga menderita hipertensi?
2. Tidak
Seberapa
banyak
mengkonsumsi
perhari
anda
garam
sebelum
dapur
menderita
hipertensi?
4.
banyak
mengkonsumsi
anda
garam
setelah
dapur
menderita
Seberapa
2. Jarang, jika konsumsi garam
1. Sering, jika konsumsi garam
≥1 sendok teh per hari.
2. Jarang, jika konsumsi garam
3 kali
sesudah menderita hipertensi?
dalam seminggu.
2. Jarang, jika ≤3 kali seminggu
mengkonsumsi
makanan
berlemak dan / atau gorengan
7.
8.
Apakah anda memiliki kebiasaan
1. Ya
merokok ?
2. Tidak
Apakah anda memiliki kebiasaan
mengkonsumsi alkohol ?
1. Ya
118
2. Tidak
9.
Seberapa
banyak
mengkonsumsi alkohol
anda
1. Iya, saya memiliki kebiasaan
sebelum
mengkonsumsi alkohol ≥ 2
menderita hipertensi?
gelas perhari.
2. Iya, saya memiliki kebiasaan
mengkonsumsi alkohol < 2
gelas perhari.
10.
Seberapa
banyak
mengkonsumsi
alkohol
anda
1. Iya, saya memiliki kebiasaan
setelah
mengkonsumsi alkohol ≥ 2
menderita hipertensi?
gelas perhari.
2. Iya, saya memiliki kebiasaan
mengkonsumsi alkohol < 2
gelas perhari.
11.
Apakah anda melakukan olahraga
1. Saya
melakukan
secara teratur sebelum menderita
tertentu
seminggu
hipertensi?
dengan
waktu
olahraga
3
kali
sekitar
30
menit.
2. Saya tidak pernah melakukan
kegiatan
olahraga
secara
teratur.
12.
Apakah anda melakukan olahraga
1. Saya
melakukan
secara teratur sebelum menderita
tertentu
seminggu
hipertensi?
dengan
waktu
olahraga
3
kali
sekitar
30
menit.
2. Saya tidak pernah melakukan
kegiatan
olahraga
secara
teratur.
13.
Apakah
anda
saat
ini
1. Ya, saat ini saya sedang
mengkonsumsi obat anti hipertensi
mengkonsumsi
?
hipertensi.
obat
anti
119
2. Tidak, saat ini saya tidak
sedang mengkonsumsi obat
anti hipertensi.
14.
Berapa macam jumlah obat anti
hipertensi yang anda konsumsi saat
ini ?
1. Saat ini mengkonsumsi 1 jenis
obat anti hipertensi.
2. Saat ini mengkonsumsi >1
jenis obat hipertensi.
15.
Apakah anda tahu bahwa hipertensi
1. Tidak tahu
adalah
2. Tahu
faktor
risiko
penyakit
jantung koroner ?
16.
Apakah anda pernah memeriksakan
1. Pernah
faktor
2. Belum pernah
risiko
penyakit
jantung
koroner yang lain, seperti DM dan
kolestrol tinggi ?
17.
Bagaimana
hasil
faktor risiko tersebut ?
pemeriksaan
1. Ada kelainan, dengan
2. Tidak ada kelainan
120
Lampiran 6. Surat Perijinan Penelitian
121
Lampiran 7. Surat Telah Melakukan Penelitian
122
Lampiran 8. Ethical Clearence
123
124
Lampiran 9. Biodata Mahasiswa
Identitas
Nama
: Reza Rachman
NIM
: 22010112110033
Tempat / tanggal lahir
: Pati, 6 Desember 1993
Jenis kelamin
: Laki - laki
Alamat
: Jalan Mediatama E 11 Perumahan Taman Setiabudi
Banyumanik, Semarang
Nomor HP
: 0811270281
: [email protected]
Riwayat Pendidikan Formal
1. SD
: 2000 Lulus tahun : 2006
2. SMP
: 2006 Lulus tahun : 2009
3. SMA
: 2009 Lulus tahun : 2012
4. FK UNDIP Masuk tahun 2012
Keanggotaan Organisasi
1. Staf SENIOR HIMA KU 2012/2013
Pengalaman penelitian
1. Judul : Faktor Risiko Kejadian Hipertensi pada Pasien yang Berobat di Poliklinik
RSUD RAA Soewondo Pati.